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Summary
The aim of this research was to further the existing 
information on the human protein known as alpha uterine protein (AUP). 
Several independent lines of research were pursued and the following 
results were reported;
1, AUP from two of the major sources known, namely uterine decidua 
and amniotic fluid, was found to be immunologically- and electrophoret- 
ically-identical. This confirms a previous report of identity between 
AUP from these two sources. In addition, the molecular weight of 
amniotic fluid AUP was estimated by gel filtration to be approximately 
53,700 daltons, which is similar to that previously estimated for 
decidual AUP by the same method.
2, An unusual peak morphology of AUP on AA.GE was observed and invest­
igated, The area enclosed by the AUP precipitin peaks was more 
deeply-staining than the surrounding gel, resulting in a "filled-in" 
appearance. This was found to be a feature of antibody/antigen 
specificity in that it was observed with antisera raised against AUP of 
decidual origin but not with antisera raised against amniotic fluid 
AUP, The exact nature of this effect remains uncertain. However, it 
may indicate incomplete antigenic identity between AUP from amniotic 
fluid and decidua, thereby contradicting the existing evidence of 
identity between AUP from these two sources, described in 1.
3, A component which may be structurally-related to AUP was detected 
in term cord serum. This was found to be of fetal rather than 
maternal origin. However, there was no evidence of immunological 
cross-reactivity between this "AUP-like" component in TCS and AUP,
4, To date, AUP has been detected in endometrium, myometrium, early 
gestation decidua, amnion, chorion and amniotic fluid. In this study, 
several other sources of AUP were discovered, namely early gestation 
(8-13 weeks) and term placenta, term decidua and mid-gestation fetal 
gut. Placental AUP was found to be electrophoretically- and immuno- 
logically-identical to that present in amniotic fluid and decidua,
5, The levels of AUP in early gestation (8-13 weeks) and term 
decidual and placental tissue were measured by one-dimensional AACE. 
Contrary to existing data on amniotic fluid AUP levels, no correlation 
between gestational age and concentration was found in either decidua
or placenta. Similar levels of AUP were detected in both these tissues 
early in gestation, although the concentration in decidua was slightly 
higher than that in placenta at each stage of gestation. An overall 
decrease in AUP concentration towards term was observed in the decidua 
and placenta. However, the decline in concentration was much greater 
in placental tissue and only trace amounts of AUP were detectable at 
term,
6, An attempt to purify AUP from amniotic fluid by the three-step method 
of antibody affinity chromatography, ion exchange chromatography and
gel filtration previously used to purify AUP from 11 week gestation 
decidua was unsuccessful. However, a two-step procedure involving 
ion exchange chromatography and Goncanavalin-A Sepharose chromatography 
gave better results. The resultant partially-purified material was 
enriched with AUP by approximately 21-fold and the concentration of 
the major contaminant protein, serum albumin, was reduced to about “  
of the initial level. However, no further purification was performed 
due to the relatively low yield of AUP obtained from the Con-A Sepharose 
chromatography step. The partially-purified AUP was radioiodinated
125with I and immune precipitates were analysed by SDS-polyacrylamide 
gel electrophoresis under denaturing conditions. Three components of 
molecular weights 48000, 16000 and 9000, respectively, were observed.
This may indicate that amniotic fluid AUP is structurally different 
from that present in decidual tissue. However this observation awaits 
further confirmation,
7, The origin of AUP in amniotic fluid was investigated by comparing 
levels of this protein in samples of 2nd trimester amniotic fluid with 
levels of several serum proteins and two non-serum proteins; al,4- 
glucosidase and prolactin. The concentrations of the latter two 
proteins between 10 weeks of gestation and term vary in a similar manner 
to the concentration of AUP. Hence a common origin in amniotic fluid 
for these three proteins is likely. In contrast, the concentration 
profile of the major serum proteins in amniotic fluid is markedly 
different during this period of gestation, A positive correlation was 
found between levels of albumin, Gc and a^-antitrypsin in the amniotic 
fluid samples, which supports other evidence that these proteins have a 
common maternal serum origin. In contrast, no correlation was found 
between levels of AUP and either prolactin or al,4-glucosidase, This 
suggests that the origin of AUP and al,4-glucosidase in amniotic fluid 
may differ. In the case of prolactin, however, no conclusions can be 
made because the assay results were not included in the final statistical 
analysis due to a non-linearity. Therefore a common origin in amniotic 
fluid for AUP and prolactin cannot be discounted,
8, Immunological identity was found between AUP and progestagen- 
dependent endometrial protein (PEP),
9, A progesterone-binding study was carried out using the method of 
equilibrium dialysis to investigate the possibility that AUP functions 
as a progesterone-receptor in vivo. However, no evidence of specific 
binding of progesterone to AUP was found.
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INTRODUCTION
Introduction
The scope of research on amniotic fluid proteins
In recent years there has been a marked increase in research 
on the proteins in amniotic fluid. In particular, there has been con­
siderable interest in the search for fetal- and pregnancy-specific 
proteins. This follows the discovery of an association between raised 
levels of alphafetoprotein (AFP) and fetal neural tube defects, especially 
anencephaly and spina bifida (Brock and Sutcliffe, 1972), Alphafeto­
protein is a fetal serum protein synthesised in fetal liver and yolk sac 
(Gitlin and Boesman, 1967; Gitlin and Perricelli, 1970), There is 
evidence that the yolk sac begins synthesising AFP by the 6th week of 
gestation, whereas the liver commences synthesis even earlier at around 
4 weeks of gestation (Gitlin and Biasucci, 1969; Gitlin and Perricelli,
1970), By the end of the frist trimester, the yolk sac has degenerated 
and become atretic, therefore no longer contributes to the fetal serum 
AFP pool. The liver, however, continues to synthesise AFP throughout 
gestation, with maximum concentrations reached in fetal serum around 13 
weeks of gestation. Although the total amount of serum AFP synthesised 
continues to increase until 20 weeks' gestation, the concentration in 
serum decreases after the 13th week because the fetal growth rate exceeds 
the rate of AFP synthesis during this period (Gitlin and Boesman, 1967), 
Fetuses affected with neural tube defects have normal AFP levels (Brock, 
1974; Seller £t al, 1974; Seppala and Ruoslahti, 1974), therefore the 
increased levels in the surrounding amniotic fluid are thought to be due 
to either leakage of fetal cerebrospinal fluid or to transudation of 
AFP from fetal capillaries in contact with the amniotic fluid.
Elevated levels of AFP in amniotic fluid have also been linked with
II II
other fetal disorders e.g. congenital nephrotic syndrome (Seppala £t al, 
1967) and exomphalos (de Bruijn and Huisjes, 1975; Nevin and Armstrong,
II II
1975; Seppala et al, 1976), although in the latter case at least 50% 
of affected fetuses have other malformations, including anencephaly 
(McKeown et 1953).
There is also evidence of an association between abnormal 
levels of some enzymes in amniotic fluid and inborn errors of metabolism. 
For measurements of enzyme activities in amniotic fluid to be of 
diagnostic value, the enzyme in question must be shown to be derived 
exclusively from the fetus. This has proved to be a major problem in 
such studies. For example, Tay-Sachs disease and Hunter's syndrome 
are genetic disorders which are characterised by the deficiency of the 
enzymes hexosaminidase A and iduronate sulphatase, respectively, in the 
tissues of the affected fetus. There is a parallel deficiency of 
these enzymes in the amniotic fluid, and this has been used to identify 
these disorders in utero (Schneck e_f al, 1970; O'Brien ^  al, 1971; 
Friedland ^  1971; Navon and Padeh, 1971; Liebaers al^ , 1977),
In some cases of both Tay-Sachs disease and Hunter's syndrome, however, 
residual enzyme activity has been detected in the amniotic fluid.
This indicates an additional source of these enzymes in the fluid, 
possibly maternal (Friedland et al, 1971; Liebaers e_t » 1977;
Geiger et al, 1978), and raises doubts about the reliability of these 
assays for prenatal diagnosis. Other factors which present problems 
when assaying enzymes associated with genetic disorders include the 
possibility of blood contamination of samples, the wide variability of 
"normal" levels of enzymes in amniotic fluid (Sutcliffe, 1981), and the 
possible presence of fetal isoenzymes not affected by the disease
(Burton et al, 1974). It is therefore apparent that further investi­
gation as to the nature and origin of the enzymes present in amniotic 
fluid, and the exact effect(s) of the genetic disorder in question is 
required in order to determine the usefulness of enzyme studies in 
prenatal diagnoses.
Measurement of levels of fetal-specific proteins present in 
amniotic fluid during gestation may also serve as an index of fetal 
maturity. The estimation of fetal lung maturity is of particular 
importance because it is used to predict respiratory distress syndrome 
in newborn infants. The amount of phospholipids present in amniotic 
fluid, especially the ratio of lecithin to sphingomyelin (Gluck ^t al,
1971) is used to assess fetal lung development. This test is based on 
the rationale that the phospholipids, especially lecithin, present in 
the amniotic fluid originate principally from the fetal lungs, A 
great deal of indirect evidence supports this hypothesis, e,g, the fatty 
acid composition of amniotic fluid and pulmonary lecithins are similar, 
but differ from those of the lecithins present in fetal skin, membranes, 
saliva, urine, placenta and maternal blood (Gluck et al, 1971), In 
addition, several studies have indicated the direct passage of fluid 
from the fetal lungs into the amniotic cavity (Setnikar e^ al, 1959; 
McLain, 1973; Gluck et al, 1974), However, there is as yet no 
unequivocal evidence that pulmonary phospholipids enter the amniotic 
fluid, Gondorelli e_t ^  (1974) investigated the possibility of extra- 
pulmonary sources of amniotic fluid phospholipids by injecting ^^C-pal- 
mitate intravenously into three sheep fetuses at or near term, and 
examining the isotopic distribution in the lipids of pulmonary fluid, 
amniotic fluid, allantoic fluid, fetal serum and urine. The sampling
method used effectively isolated the fetal pulmonary fluid compartment 
from the mouth, gastrointestinal tract and amniotic fluid. Despite 
this, radiolabelled phospholipids were present in all the fluids 
examined, including amniotic fluid. Thus, it is possible that there 
are extrapulmonary sources of amniotic fluid phospholipids. On the 
basis of both quantitative and qualitative examinations of the phospho­
lipids in the various compartments, the authors suggested that fetal 
serum and/or urine may contribute to a major extent to amniotic fluid 
phospholipids. However, since the pulmonary compartment was isolated 
in this experiment, a contribution from the fetal lungs cannot be 
excluded. If the extrapulmonary contribution proves to be greater 
than that from the fetal lungs then the phospholipid test would reflect 
pulmonary maturation as a function of the general development of the 
fetus, rather than lung maturity itself. Thus, alternative markers 
of fetal lung development may be sought in the future.
One such marker which may prove useful in the assessment of 
fetal lung maturity is pulmonary apoprotein which is present in amniotic 
fluid (King et al, 1975), This apoprotein, which was first isolated 
from adult human pulmonary surfactant, consists of three components of 
molecular weights 69000 (identified as albumin), 34000 and 11000, 
respectively. It is possible that the 34000 dalton component is 
identical to the pulmonary glycoprotein of similar molecular size 
reported in the alveoli of patients with alveolar proteinosis and lung 
lavage material of normal animals (Bhattacharyya £t 1975, 1976a,b; 
Bhattacharyya and Lynn, 1977a,b), and in human amniotic fluid (Bhatta­
charyya and Lynn, 1978), Using an antiserum raised against adult 
surfactant apoprotein and subsequently adsorbed with adult serum to
10
remove the albumin specificities, King and associates (1975) detected 
this apoprotein in amniotic fluid throughout gestation, but failed to 
detect it in human serum, neonatal skin homogenate, nasal mucus, 
saliva or the first urine excreted by ten infants, A pulmonary origin 
for this apoprotein in amniotic fluid therefore appears likely. The 
discovery of a negative correlation between the concentration of apo­
protein in amniotic fluid and the subsequent development of respiratory 
distress syndrome indicates the possibility of using this measurement 
(or the concentration of one of the constituent proteins) as an index 
of fetal lung maturity.
It is also possible that some uterine-specific proteins are 
present in the amniotic fluid. The decidua in particular is a 
potential source of amniotic fluid proteins due to its close proximity 
to the amniotic cavity. In addition, evidence from in vitro dialysis 
experiments indicates that passage of proteins can occur across the 
"reflected" fetal membranes into the amniotic fluid (Abbas and Tovey, 
1960), In this study only the passage of maternal serum proteins 
across the amnion and chorion was demonstrated. However, there was 
also evidence that molecular size was the major factor restricting 
passage of proteins across these membranes. Therefore, it is likely 
that uterine proteins within the molecular size range for passive 
diffusion across the fetal membranes will likewise enter the amniotic 
fluid.
Abnormal levels of uterine proteins present in the amniotic 
fluid may indicate some uterine dysfunction. However, most uterine 
disorders associated with pregnancy occur early in gestation and 
generally prevent implantation of the fertilised ovum or cause abortion 
soon after implantation. For example, a major uterine dysfunction
11
during pregnancy is insufficient transformation of the endometrium 
(Antoine, 1971), This may prevent implantation, or if implantation 
occurs, the endometrium is unable to support fetal development before 
the establishment of materno-fetal exchange. Uterine-specific 
proteins may play an important role in the above mechanism, though this 
subject is pootly understood as yet.
As previously mentioned, it is possible that some uterine 
proteins enter the amniotic fluid by passive diffusion. If this is 
the case, an inverse relationship between their concentrations in 
amniotic fluid and molecular size would be expected, as is found for 
maternal serum proteins (Abbas and Tovey, 1960), The presence of 
uterine proteins in concentrations above the expected levels may indicate 
active transport of these proteins into the fluid. Such proteins are 
likely to serve an important function either within the amniotic fluid 
or within the fetus. Measurement of the levels of uterine-specific 
proteins in amniotic fluid may therefore provide some indication of 
fetal well-being. Thus, the search for uterine-specific proteins in 
amniotic fluid is important because information about the nature and 
function of such proteins may aid our understanding of maternal-fetal 
interactions during gestation.
Possible functions of human uterine-specific proteins during gestation
At the present time, the functions of very few human uterine- 
specific proteins have been established (see section of Introduction 
entitled "Mammalian uterine proteins,"). However, from our limited 
knowledge of materno-fetal interactions during pregnancy and information
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about the uterine proteins of other mammals, several possible functions 
of human uterine proteins may be outlined.
For example, uterine-specific proteins may be involved in 
fetal nutrition during the first 3 to 4 weeks of gestation, before 
vascular exchange is established between mother and fetus. During the 
pre-implantation period, the developing embryo derives its nutrition 
from "uterine milk" secreted by the endometrial glands. During implant­
ation, the invading placental trophoblast phagocytoses decidual tissue 
and blood cells, thus supplying essential proteins to the fetus.
After materno-fetal exchange is established most of the 
nutritional needs of the fetus are obtained from the maternal circulation 
via the placenta. It is possible, however, that after this stage some 
proteins are transferred across the reflected fetal membranes from the 
parietal decidua into the amniotic fluid and make an additional minor 
contribution to fetal nutrition.
Other possible functions of human uterine proteins include a 
role in the regulation of pre- or post-implantation embryonic develop­
ment. This has been suggested as a possible function for progestagen- 
dependent endometrial protein (Joshi ^  aJL, 1980b), a recently charac­
terised human uterine protein (see section of Introduction entitled 
"Progestagen-dependent endometrial protein"). There is evidence that 
uterine-specific proteins serve such a regulatory function in some 
other mammals. For example, in the cow, four non-serum uterine proteins 
appear in the uterine fluid just before the phase of rapid embryonic 
elongation, hence may be involved in the regulation of this process 
(Roberts and Parker, 1974, 1976; Gibbons et al, 1977), Alternatively,
13
uterine proteins may be involved in establishing optimal conditions for 
implantation. There is some evidence that uteroglobin (see section on 
"Mammalian uterine proteins") may serve a similar function in the 
rabbit (Krishnan, 1971; Allen and Foote, 1973; McCarthy et al, 1977),
Another important function of human uterine proteins may be 
the transportation of essential elements from mother to fetus. For 
example, the purple protein of the pig is believed to be involved in 
the transport of iron (Bazer, 1975) because each molecule of purple 
protein binds one atom of iron. The binding and transportation of 
steroid hormones is an important process during gestation, because the 
association of oestrogen or progesterone to specific receptor proteins 
results in de novo synthesis of new proteins which in turn may perform 
essential functions during pregnancy. Uteroglobin is known to bind 
progesterone (see section on "Mammalian uterine proteins") and the 
discovery of a significant correlation between progesterone content 
and protein content of rabbit uterine fluid during pseudopregnancy 
suggests that it may serve this function in vivo (Fowler ^  al, 1976; 
Borland e_t al, 1977),
Alpha uterine protein (AUP) ; discovery, distribution and properties
Alpha uterine protein is a soluble protein of Œ2"Mobility on 
two-dimensional antibody antigen crossed electrophoresis (21) AAGE) which 
is present in both the pregnant and non-pregnant human uterus, AUP 
was first discovered by Sutcliffe and associates (1978) during a search 
for novel fetal- or pregnancy-specific proteins in human amniotic fluid. 
The experimental method used was a subtractive procedure which they
14
termed "negative antibody affinity chromatography". This involved the 
passage of pooled amniotic fluid samples of 14-16 weeks' gestation 
over a series of two Sepharose columns to which were co upled sheep 
antibodies to human serum proteins, and sheep antibodies to human 
alphafetoprotein, respectively. The resultant unadsorbed material 
eluted from the second column contained approximately 3% of the total 
protein present in the original amniotic fluid pool. This was used to 
immunise rabbits and an antiserum obtained. The antiserum was found 
to contain antibodies directed against six non-serum proteins in 
amniotic fluid, of which one was also specific to human uterine decidua. 
This protein, designated "alpha uterine protein" was also detected by 
AA.GE in endometrium, myometrium, amnion and chorion, but was not 
detectable in maternal serum or homogenates of human male liver, gut, 
kidney, lung or skin by this method.
In a subsequent study (Sutcliffe £t al, 1980), AUP was 
purified from 11 week gestation human decidua by a three-step method of 
affinity chromatography, ion exchange chromatography and gel filtration. 
Affinity chromatography was performed on a column of Sepharose to which 
were coupled antibodies raised against amniotic fluid AUP in the previous 
study. After this step there was a 39% recovery of iramunoadsorbed AUP, 
This material was applied to a column of DEAE-Sepharose and eluted with 
a linear gradient starting with 500 ml of 10 mM potassium phosphate 
(pH 7,8) and ending with 500 ml of 10 mM potassium phosphate, 0,2M 
sodium chloride (pH 6,5), Under these conditions, AUP was eluted from 
the column at a mean salt concentration of 0.13M NaCl (compared to 0.18M 
NaCl for serum albumin). From the final gel filtration step on 
Sephadex G-150, a molecular weight estimate of 50,000 was obtained for AUP,
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The resultant purified material was radio-iodinated using I and 
immune precipitates were analysed by SDS-polyacrylamide gel electro­
phoresis, A single band corresponding to a molecular weight of 
approximately 23000-25000 daltons was found. These data suggest 
that AUP is a dimer, composed of two similar or identical polypeptide 
chains. Evidence of antigenic identity between AUP, decidua and 
endometrium was obtained by tandem crossed electrophoresis using two 
different antisera: raised in rabbit against amniotic fluid AUP and
decidual AUP, respectively. In addition, AUP from these three 
sources gave arcs of identical mobility when run separately on two- 
dimensional AACE plates. Levels of AUP in amniotic fluid do not 
remain constant throughout gestation, Sutcliffe £t ^  (1978) measured 
AUP concentration in samples of amniotic fluid between 12 weeks of 
gestation and term by one-dimensional AACE (see methods section),
A wide range of values was found during this period (see 
Fig 1), It is evident that in the amniotic fluid samples examined 
maximal concentrations of AUP occur around 15-18 weeks' gestation, 
after which there is a gradual decline to term. It must be emphasised,
however, that the concentration of AUP in amniotic fluid before 12 weeks
of gestation has not been measured, due to the difficulty of obtaining 
samples of amniotic fluid from early gestation. Therefore, it is 
possible that the peak concentration of AUP in the fluid may occur 
during the first trimester, and that the values shown on this graph 
represent a progressive decline in concentration after the peak.
Possible sites of AUP synthesis, and routes of entry into amniotic fluid
The exact site of synthesis of AUP is not yet known, although
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in view of its consistent presence in both pregnant and non-pregnant 
uterine tissue the uterus appears to be the most likely source. Low 
concentrations of AUP are also detectable in amnion and chorion, 
therefore the fetal membranes may be an additional site of synthesis* 
Alternatively, the AUP present in these membranes may be derived from 
the decidua.
If AUP is synthesised in uterine decidua there are two possible 
routes of entry into the amniotic fluid: via the placental barrier or
via the reflected fetal membranes. In order to cross the placenta, a 
decidual protein would have to enter the maternal blood which leaves the 
spiral arteries in the uterus then circulates between the placental 
villi and flows along the chorionic plate. It would then have to cross 
the chorionic plate and associated amnion in order to enter the amniotic 
fluid. Previous studies have indicated that serum proteins of molecular 
weight less than 170,000 daltons can permeate into the amniotic fluid 
(Usategui-Gomez e_t al^ , 1966; Gitlin and Biasucci, 1969; Sutcliffe and 
Brock, 1972) therefore AUP is well within the molecular weight range 
for passive diffusion across the placental barrier. This route of 
entry, however, is unlikely for several reasons. Firstly, maternal 
blood entering the intervillous spaces is under considerable pressure 
which forces it towards the chorionic plate (Boyd and Hamilton, 1970; 
Corliss, 1976), Hence the chorionic plate is engulfed with maternal 
blood which would inhibit free diffusion of uterine proteins across the 
placental barrier. The inability to detect AUP in maternal serum also 
argues against this route of entry. Since the chorionic plate and 
amnion are the only barrier between the maternal circulation and the 
amniotic fluid this is the most likely route of entry of maternal
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serum proteins into the fluid. Therefore, if AUP entered the amniotic 
fluid along with maternal serum proteins, its concentration throughout 
gestation would be expected to vary in a similar manner to that of 
known maternal serum proteins. Clearly, this is not the case for 
AUP (see following section).
The alternative route of entry of AUP into the amniotic 
fluid is via the reflected amnion and chorion which lie outwith the 
placenta in close apposition to the decidua. In this area of the 
uterus, the reflected membranes are not engulfed by maternal blood 
because the decidual blood supply does not leave the capillary system. 
Therefore uterine proteins are more likely to enter the amniotic fluid 
by this more direct route.
Concentration changes during gestation and possible origins of 
prolactin gl,4-glucosidase, heat-labile alkaline phosphatase and some 
serum proteins in amniotic fluid
The concentration profile of AUP in amniotic fluid during 
the second and third trimesters of gestation is strikingly similar to 
that of the enzyme al,4-glucosidase and the pituitary hormone prolactin 
during this period (Sutcliffe and Brock, 1972; Sutcliffe e_t al, 1972b; 
Tyson e_t 1972; Ghochinov £t 1976; Clements e_t al, 1977), 
Another enzyme present in amniotic fluid, heat-labile alkaline phos­
phatase, has an initial peak of activity between 13 and 18 weeks of 
gestation, followed by a second activity peak towards term, A close 
correlation has been observed between the levels of al,4-glucosidase 
and heat-Labile alkaline phosphatase in individual amniotic fluid 
samples during the early activity peak (Sutcliffe e_t al, 1972b) which
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may indicate a similar tissue of origin for these two enzymes 
(Sutcliffe and Brock, 1972).
Serum proteins
Alpha uterine protein, prolactin, cel,4-glucosidase and heat- 
labile alkaline phosphatase are all relatively minor components of 
amniotic fluid. The variation in concentration throughout pregnancy 
of these proteins differs markedly from that of the quantitatively 
major protein components in amniotic fluid, which are of serum origin.
This latter group consists of serum albumin and some other relatively 
low molecular weight serum proteins including o:^-antitrypsin, transferrin 
and group-specific component (Gc), The concentration profile of these 
proteins parallels that of the total soluble protein in amniotic fluid, 
i.e. the concentration rises from about 10 weeks of gestation to reach 
a maximum between 20 and 30 weeks after which there is a decline to 
term (Queenan et al, 1970; Sutcliffe and Brock, 1972), Genetic studies 
indicate that group-specific component, transferrin and orosomucoid 
are of maternal rather than fetal origin (Ruoslahti £t al, 1966; Usategui-
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Gomez and Morgan, 1966; Seppala ^  al^ , 1966; Sutcliffe e_t al, 1972a; 
Johnson et al, 1974), In addition, evidence from quantitative studies 
suggests that most other serum proteins in amniotic fluid are also 
derived from the mother, and it is widely believed that these proteins 
enter the amniotic fluid by passive diffusion of maternal serum 
across the chorionic plate and amnion (Abbas and Tovey, 1960; Strebel, 
1960; Derrington and Soothill, 1961; Gitlin et al, 1964; Gitlin and 
Biasucci, 1969; Sutcliffe and Brock, 1973; Johnson et al, 1974),*
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In view of the evidence that serum proteins which reach 
maximal levels in amniotic fluid between 20 and 30 weeks' gestation 
have a common maternal origin, it is possible that AUP, prolactin 
and al,4-glucosidase which have identical concentration profiles through­
out gestation also have a common origin. This may also be the case 
for heat-labile alkaline phosphatase early in gestation. The exact 
origin of these four proteins in amniotic fluid, however, is by no 
means certain.
Prolactin
Several sources of amniotic fluid prolactin have been 
suggested, including maternal serum (Josimovich ^  al, 1974; Schenker 
et al, 1975), fetal serum (Fang and Kim, 1975; Chochinov et al, 1976), 
placenta (Friesen et al, 1972; McNeilly et al, 1976), placental 
membranes and decidua (Riddick and Kusmik, 1977; Riddick et al, 1978; 
Golander e^t al, 1978; Healy e^t al, 1979), A serum origin for prolactin 
is unlikely because the concentration of prolactin in amniotic fluid
* There is some dispute, however, about the origins in amniotic
fluid of albumin and a anti trypsin (Brzezinski et al,1964; Kaiser £t 
al, 1974), Brzezinski and associates reported a rare case of fetal 
bisalbuminemia in which the variant form of albumin was found in the 
amniotic fluid and fetal serum but was absent from the maternal serum. 
They concluded that the albumin in amniotic fluid originates from the 
fetus. There was no evidence, however, that the additional "bisalbumin" 
peak visualised as a small supe rimposed peak close to the normal albumin 
peak was antigenically-related to albumin, and no examination was made 
of the paternal serum to discover if this trait was inherited. Thus, 
it is possible that the "bisalbumin" peak was an artefact, A fetal 
origin has also been proposed for oc^-antitrypsin (Kaiser et al, 1974), 
This was based on a single case of a^-antitrypsin deficiency in which 
a heterozygous mother carrying a fetus homozygous for this trait was 
found to have amniotic fluid levels of ct,-antitrypsin at term which 
were less than 10% those of control fluids. Unfortunately, the 
concentration of a, antitrypsin in amniotic fluid was too low for 
phenotyping to be done.
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between 13 and 18 weeks of gestation exceeds that in maternal and fetal 
sera by about 100-fold (Tyson e^ al, 1972; Winters £t al, 1975;
Clements et al, 1977). Towards term, however, the concentration of 
prolactin in amniotic fluid falls while that in maternal and fetal sera 
rises, to levels within the same range (Tyson e_t 1972; Winters et al, 
1975; Fang and Kim, 1975; Clements et al, 1977), thus a serum origin 
cannot be discounted at this stage of gestation, Riddick and Kusmik 
(1977) cultured explants of decidua, placenta and placental membranes 
obtained from normal pregnancies at delivery and measured the concen­
tration of prolactin in the incubation media and tissue homogenates.
In the decidual cultures there was a progressive increase in prolactin 
concentration in the incubation medium with time, and the total amount 
of prolactin released during culture exceeded that present in the 
tissue at the beginning of the incubation period. In contrast, very 
small amounts of prolactin were released by the other tissues cultured.
The authors concluded that de novo synthesis of prolactin by decidua 
occurred during incubation. In a similar experiment, Golander and 
associates (1978) found that explants of chorion-decidua secreted 
prolactin over a 6 day culture period at a relatively constant rate.
De novo synthesis was demonstrated directly by the incorporation of 
radiolabelled amino acids into the prolactin. In addition, cycloheximide 
treatment resulted in a reduction of the prolactin concentration in the 
explants and culture media. It therefore appears likely that the 
decidua and possibly the chorion synthesise and secrete prolactin and 
that these tissues may be the major source of this hormone in amniotic 
fluid.
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Alpha 1,4-glucosidase and heat-labile alkaline phosphatase
By comparing the concentration gradients of al,4-glucosidase 
and heat-labile alkaline phosphatase between serum and amniotic fluid 
with those of the maternal serum marker Gc, and the fetal serum marker 
AFP, Sutcliffe and Brock (1972) found that the specific activities of 
both enzymes were much higher than expected on the basis of either a 
maternal or fetal serum origin. Other possible sources of amniotic 
fluid enzymes include maternal non-serum (uterine decidua and myometrium), 
fetal skin, urine, respiratory and alimentary secretions, amnion, 
chorion, amniotic fluid cells and umbilical cord, Amniotic fluid 
cells are unlikely to be the source of al,4-glucosidase or heat-labile 
alkaline phosphatase because the cell concentration is low at the time 
of the early specific activity peak of these enzymes (Nelson and Emery, 
1970), In addition, at term when the amniotic fluid cell concentration 
is maximal (Nelson and Emery, 1970), between 29 and 56 times as much 
heat-labile alkaline phosphatase is present in the supernatant of 
amniotic fluid than in the cells (Sutcliffe and Brock, 1972), A 
fetal origin has been suggested for both these enzymes (Salafsky and 
Nadler, 1971a,b; Mulivor et al, 1979), Salafsky and Nadler (1971a)
detected al,4-glucosidase activity in the amniotic fluid and kidney of
three patients with Pompe's disease, but failed to detect this enzyme 
in the liver, leucocytes, cultivated fibroblasts or cultivated amniotic 
fluid cells of these patients. The al,4-glucosidase present in 
amniotic fluid and kidney of both control patients and those with
Pompe's disease was found to differ from the enzyme present in the
other tissues examined with respect to pH optimum and inhibition by 
turanose. This evidence suggests that the al,4-glucosidase in amniotic
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fluid and kidney is a different enzyme from lysosomal #1,4-glucosidase 
which is deficient in Pompe's disease, Amniotic fluid al,4-glucosidase 
has been further characterised (Fluharty et al, 1973). Other differ­
ences between this enzyme and lysosomal al,4-glucosidase include 
thermal stability and response to O.IM potassium chloride, A fetal 
origin for the al,4-glucosidase in amniotic fluid is therefore possible. 
Fetal kidney, however, is unlikely to be a major source of this enzyme 
because levels in fetal urine are very low between 13 and 18 weeks of 
gestation (Sutcliffe et al, 1972b), In a further study, Salafsky and 
Nadler (1971b) reported that 85% of the al,4-glucosidase activity in 
second trimester amniotic fluid was localised within intracellular 
organelles, and suggested that these originate from lysed fetal cells. 
Other possible sources of amniotic fluid al,4-glucosidase, for example 
fetal secretions, uterine decidua and myometrium remain to be 
investigated.
There are several different types of alkaline phosphatases 
in human tissues (Suzuki ^  1969) which can be differentiated
according to their thermal stability and inhibition by L-phenylalanine 
and L-homoarginine, Mulivor e_t ^  (1979) investigated the origin of 
the alkaline phosphatases in amniotic fluid and found that the 
intestinal type of heat-labile alkaline phosphatase comprises most of 
the total alkaline phosphatase activity present in amniotic fluid 
until around 25 weeks of gestation, with a peak of activity occurring 
around 20 weeks. This coincides with the early activity peak reported 
by Sutcliffe and Brock (1972), Electrophoretic evidence indicated 
that this enzyme was of fetal rather than maternal origin. Between
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25 and 40 weeks of gestation, however, the greatest proportion of the 
total enzyme activity is due to the bone, liver, kidney type of heat- 
labile alkaline phosphatase, A fetal origin is also likely for this 
form of the enzyme, since there is no corresponding increase of this 
enzyme in maternal serum at this stage of gestation.
Mammalian uterine proteins
A variety of human uterine-specific proteins have been 
detected previously (see Aitken, 1979b), Most studies have involved 
analysis of human uterine fluid throughout the menstrual cycle rather 
than a direct examination of the proteins present in uterine tissue.
In man, and all other mammals examined to date, at the time of 
ovulation the uterus produces a voluminous secretion which is rich in 
proteins, (Lutwak-Mann £t al, 1960; Fahning, 1965; Aitken, 1970, 1977a; 
Clemetson et al, 1973; Meglioli et al, 1973), This dilates the 
uterine lumen thus aiding the movement of sperm towards the oviduct 
(Aitken, 1979a), In most mammals there is another marked increase in 
protein content of the uterine secretions during the preimplantation 
period. These uterine secretions, which comprise a complex mixture 
of proteins (Surani, 1977; Aitken, 1977b) are thought to be involved 
in the induction and maintenance of blastocyst activity during implant­
ation (Aitken, 1979a). In some mammals, for example the pig and 
rabbit, this progestational phase is characterised by the appearance 
of a dominant non-serum protein in the uterine lumen. In the pig, 
this dominant component is a purple-coloured glycoprotein of about 
32000 molecular weight (Squire £t al, 1972; Bazer, 1975) which is 
synthesised in the cells of the luminal and glandular epithelia of the
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endometrium. Maximum synthesis occurs during the midluteal phase, 
under the influence of progesterone (Chen et al, 1975; Bazer, 1975),
The function of this protein is not known: it may have a role in the
elongation of the blastocyst or may be involved in the transport of 
iron (Aitken, 1979b), In the rabbit, the major protein present at 
this time is a protein variously termed blastokinin (Krishnan and 
Daniel, 1967) or uteroglobin (Beier, 1968), This protein was first 
isolated from rabbit uterine fluid, where it reaches maximum concen­
tration on day 5 post-coitum i,e, just before blastulation occurs in 
vivo (Krishnan and Daniel, 1967), In later studies, immunological 
identity was established between uteroglobin and "cone-forming" protein, 
which is present in the oviducal fluid of normal oestrous rabbits 
(Kay and Feigelson, 1972; Noske and Feigelson, 1976; Feigelson et al, 
1977), To date, uteroglobin has been detected in both oestrous and 
pregnant rabbit oviducal and uterine fluids, endometrium, myometrium, 
ovary, oviduct, vaginal tissue, blastocoelic fluid and preimplantation 
blastocyst coverings, male rabbit reproductive tract and flushings, 
and various non-reproductive sites including lung, trachea, oesophagus, 
thyroid and bladder (Krishnan and Daniel, 1967; Beier, 1968; Kirchner, 
1972, 1976; Hamana and Hafez, 1970; Urzua ejt al, 1970; Kay and 
Feigelsen, 1972; Goswami and Feigelson, 1974; Petzoldt, 1974;
Beier and Maurer, 1975; Beier e_t al, 1975; Noske and Feigelson, 1976; 
Feigelson, 1976; Kirchner and Schroer, 1976; Beato and Beier, 1978; 
Noske and Gooding, 1978), The biochemical composition of uteroglobin 
has been determined: it is a globular protein of molecular weight
14000-16000, comprising two similar or identical polypeptide chains, 
which contains little or no carbohydrate (Murray £t al, 1972; McGaughey
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and Murray, 1972; Bullock and Connell, 1973; Nieto et al, 1977;
Beato and Beier, 1978). The amino acid sequence has been determined 
(Popp et al, 1978). Oviducal uteroglobin is specifically induced by 
oestrogens (Kay and Feigelson, 1972; Goswami and Feigelson, 1974; 
Feigelson, 1976), whereas in the uterus progesterone is the more powerful 
inducer (Urzua £t al, 1970; Bullock and Connell, 1973; Goswami and 
Feigelson, 1974; Beato and Baler, 1975; Feigelson, 1976). Ovarian 
steroids do not, however, appear to be involved in the induction of 
uteroglobin in male reproductive tissues and non-reproductive sites 
(Feigelson, 1976; Noske and Feigelson, 1976; Feigelson £t al, 1977; 
Daniel and Crowder, 1977), The exact function of uteroglobin is not 
yet established. It has the ability to bind progesterone and other 
progestational steroids (Urzua e_t al, 1970; Rahman ^  al, 1975; Beato 
and Baier, 1975; Beato, 1976; Fridlansky and Milgrom, 1976; Beato 
et al, 1977), hence may be involved in the transport of progesterone. 
Thus, uteroglobin may function as an intrauterine steroid carrier 
protein that supplies progesterone to the embryo (Arthur and Chang,
1974) where it could be used as raw material for oestrogen biosynthesis 
by the trophoblast (Perry et al, 1973), In addition, it has been 
suggested that uteroglobin may protect the embryo from the effects of 
free progesterone (Maurer and Beier, 1976) which appears to retard 
embryonic development when present in physiological concentrations. 
Uteroglobin itself appears to be embryotoxic if present in the uterus 
at the wrong stage of development, which suggests that the correct 
sequence of uterine secretory events is essential for normal embryonic 
development (Allen and Foote, 1973; Beier, 1976; McCarthy e_t al,
1977), Although uteroglobin is the quantitatively major protein in 
the uterine secretions this does not, however, exclude the possibility
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that other quantitatively minor proteins may also be important for 
the establishment of optimal conditions for implantation. There is 
also evidence that endometrial uteroglobin has proteinase-inhibiting 
activity, therefore may be involved in the proteolytic system of the 
uterus (Beier, 1970, 1976; Denker, 1972; Johnson, 1974), Finally, 
the ubiquitous distribution of uteroglobin suggests that it may have 
several functions, although these may have some underlying common 
mechanism (Feigelson, 1976),
In humans there is no corresponding increase in uterine 
secretory activity after ovulation. In contrast, both the protein 
concentration and volume of the uterine fluid are higher in the 
proliferative phase (i.e, pre-ovulation) of the menstrual cycle than 
in the secretory phase (Maathuis and Aitken, 1978a), The higher 
protein concentration in the proliferative phase may reflect endometrial 
secretory activity (Wynn and Harris, 1967), In addition, since 
oestrogen increases the permeability of the endometrial blood vessels 
(Pappas and Blanchette, 1965; Martin £t al, 1973), direct transudation 
of protein from the uterine circulation may be a contributary factor. 
There is evidence that in some mammals the implanting blastocyst may 
exert a local stimulus on endometrial secretory activity (Daniel, 1972; 
Renfree, 1972, 1973; Wyatt et al, 1976; Aitken, 1977b), This may
also occur in humans, although it awaits investigation.
Several studies have been carried out involving analysis of 
human uterine fluid throughout the menstrual cycle by polyacrylamide 
gel electrophoresis (Beier ^  al, 1970; Shirai e_t al, 1972; Beier and 
Beier-Hellwig, 1973; Daniel, 1973; Wolf and Mastroianni, 1975;
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Roberts et al, 1976; Maathuis and Aitken, 1978b), Although these 
reports vary as regards the number of non-serum proteins present and 
their electrophoretic mobilities, there is general agreement on the 
absence of a quantitatively dominant non-serum protein at any stage 
of the menstrual cycle, Maathuis and Aitken (1978b) used an improved 
flushing technique (Maathuis and Aitken, 1978a) which prevents contam­
ination of uterine fluid samples with blood, cervical mucus, tubal 
fluid or seminal plasma. They detected a total of 11 non-serum 
proteins in the uterine flushings, one of which was also present in 
peritoneal fluid, but absent from plasma. This may indicate some 
exchange of fluid between the uterine and peritoneal cavities. Similar 
protein bands were found in uterine fluids from all stages of the 
menstrual cycle suggesting a lack of an ovarian steroid hormonal control 
mechanism. In another study of this nature, Roberts and associates 
(1976) found a total of 6 uterine-specific bands at all stages of the 
menstrual cycle. One of these bands, a post-transferrin, appeared 
to increase in intensity during the late secretory phase (days 23-25), 
Bands of similar mobility have also been reported in uterine fluid 
(Beier and Beier-Hellwig, 1973; Wolf and Mastroianni, 1975; Maathuis 
and Aitken, 1978b), and in oviducal fluid (Moghissi, 1970), although 
Maathuis and Aitken (1978b) did not find any variation in its intensity 
throughout the cycle, and Wolf and Mastroianni (1975) reported a 
decrease in the concentration of this protein in post- ovulatory 
samples.
Several post-albumins are present in human uterine fluid, 
and it has been suggested that one of these bands is equivalent to 
uteroglobin (Shirai et al, 1972; Daniel, 1973), In the former study.
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a major post-albumin band of similar mobility to rabbit uteroglobin 
was found in mid-secretory phase samples of human uterine fluid.
There was no evidence however, of immunological or biochemical identity 
between this protein and uteroglobin, and the technique used to collect 
the uterine fluid samples failed to exclude blood contamination (Beier 
and Beier-Hellwig, 1973; Roberts ^  al, 1976; Maathuis and Aitken, 
1978b), This is an important factor because the electrophoretic 
mobility of uteroglobin is similar to that of haemoglobin (Roberts e^ al, 
1976), Daniel (1973) also detected a band of identical mobility to 
purified rabbit uteroglobin in a mid-secretory phase sample of human 
uterine fluid and presented evidence of immunological identity between 
this uterine flushing and blastokinin using a virtually monospecific 
antiserum raised against rabbit uteroglobin. He failed to give any 
evidence however, that the band visualised on the gel and the protein 
which cross-reacted with uteroglobin were in any way related.
In a more recent study, Noske and Feigelson (1976) claimed 
to have detected a cross-reaching antigen to "cone-forming" protein in 
human endometrium, uterine and oviducal flushings and seminal plasma.
This was based on evidence from double immunodiffusion, radial immuno­
diffusion and immunoelectrophoresis experiments. The double immuno­
diffusion experiments were particularly interesting, in that a single 
line of identity was found between a female rabbit reproductive tract 
preparation and each of human progestational phase endometrial extract 
and seminal plasma using monospecific goat antiserum to rabbit cone- 
forming protein (CP). No evidence was found of antigenic identity 
between rabbit CP and human oviducal or uterine flushings using this 
method. On immunoelectrophoresis, however, human oviducal and uterine
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flushings and progestational phase endometrial extracts gave precipitin 
arcs of similar mobilities to rabbit CP, when reacted against anti­
rabbit CP serum. A "shoulder" was observed on the precipitin arcs 
formed by the human material, but was absent from the rabbit CP arcs.
The authors suggested that this was indicative of electrophoretic 
variants of CP in the human material. However, in view of the lack of 
evidence of cross-reactivity between rabbit CP and human oviducal and 
uterine flushings, it is difficult to compare the human protein(s) 
visualised on immunoelectrophoresis with rabbit CP, These observations, 
although interesting, are as yet unconfirmed,
A variety of proteins have been detected in human uterine 
tissue, notably oestrogen-induced protein and two steroid-hormone 
receptor proteins, Villaneuva and Heinrichs (1977) reported the 
appearance of a protein in human endometrium following oestrogen 
administration. Induction of this protein occurred in both secretory 
and proliferative phase endometrium. Treatment with actinomycin-D 
prevented the appearance of this protein, suggesting that RNA-synthesis 
is an essential step in the induction process, i.e, de novo synthesis 
occurs following oestrogen administration. This protein appears to be 
very similar to an oestrogen-induced protein (IP) present in rat uterus 
(Notides and Gorski, 1966), Induced protein, which is also a product 
of de novo synthesis in the uterus (De Angelo and Gorski, 1970; Katzen- 
ellenbogen and Gorski, 1972), has been isolated and a preliminary 
characterisation performed. This protein consists of a single homo­
geneous polypeptide chain of molecular weight 45000, and is acidic in 
nature (lacobelli et al, 1973), The physiological function of IP is 
unknown. It has been suggested, however, that IP has a role in the
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mechanism of gene expression, possibly by facilitating further RNA 
synthesis or transport, which would then lead to the final expression 
of steroid action (Baulieu e^ a_l, 1972; Du Pont-Mairesse and Galand,
1975),
Both oestrogen- and progesterone-receptors are present in 
the mammalian uterus and the information available on these proteins
It
has recently been reviewed (Janne e^ 1978), These receptors are 
found in both myometrium and endometrium of the human uterus and their 
physicochemical characteristics and ligand-binding specificities have 
been established (Jensen £t al, 1969; Puca eb 1971, 1972; Martin, 
1972; Notides al, 1972; Verma and Laumas, 1973; Ratajczak and
II
Hahnel, 1974; Young and Cleary, 1974; Janne £t al, 1975; Smith e_t al, 
1975; Sanborn et al, 1975), Levels of both receptors in the mammalian 
uterus are under hormonal control, Oestrogens stimulate the formation 
of both oestrogen- and progesterone-receptors, whereas progesterone 
and progestins decrease the concentration of both receptors (Sarff and 
Gorski, 1971; Milgrom e_t al, 1972, 1973; Anderson e_t al, 1973; Leung 
and Sasaki, 1973; Mester et al, 1974; Freifeld e^ al, 1974; Master 
and Baulieu, 1975; Hsueh £t al, 1975; Luu Thi e^ al, 1975; Clark 
^  1977; Vu Hai et ja, 1977; Leavitt et al, 1974, 1977). In
addition, in the human uterus concentrations of both steroid-hormone 
receptors are higher during the proliferative phase of the menstrual 
cycle than during the secretory phase (Haukkamaa and Luukainen, 1974;
II It II
Bayard et al, 1975; Janne et al, 1976; Tseng £t ^1, 1977; Syrjala 
et al, 1978),
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Progestagen-dependent endometrial protein
There have been relatively few studies on human uterine 
proteins synthesised during gestation. Recently, however, Joshi and 
associates reported the discovery of a glycoprotein in human secretory 
phase endometrium and early gestation decidua (Joshi e_t al, 1980a,b), 
using an immunological method of detection. They failed to detect 
this protein in proliferative phase endometrium, term placenta or adult 
serum by this method. Using a more sensitive double-isotopic labelling 
technique, however, synthesis of this protein was demonstrated in early 
gestation decidua and endometrium from both phases of the menstrual 
cycle, although the rate of synthesis was much lower in proliferative 
phase endometrium than in the other two tissues. The authors therefore 
suggested that synthesis of this glycoprotein may be regulated mainly 
by progesterone. Thus, the presence of progesterone in the serum 
throughout the menstrual cycle (Moghissi e^ al, 1972) may account for 
the small amounts of this protein found in proliferative phase endo­
metrium, Due to its consistent presence in uterine tissue during the 
progestational phase, the authors named this protein "progestagen- 
dependent endometrial protein" (PEP),
Following its initial discovery, PEP was partially purified 
from the cytosol of decidua-rich tissues by Con-A Sepharose chromatog­
raphy and polyacrylamide gel electrophoresis, then further characterised 
(Joshi e_b 1980b), Immunological reactivity of PEP was not affected 
by exposure to temperatures of 40-85°C or values of pH from 2-12, 
Treatment with the enzymes pepsin, DNase, RNase and neuraminidase had 
no effect, whereas trypsin completely destroyed antigenicity, indicating 
that the antigenic determinants are located within the protein molecule
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rather than in the terminal residues. Although pepsin is also an 
endopeptidase, it attacks the peptide chain at different points from 
tryps in and is less specific. Bonds with aromatic or acidic amino 
acids are cleaved preferentially, and in addition neighbouring amino 
acids appear to influence pepsin activity. Trypsin specifically 
cleaves lysyl or arginyl bonds such that the resulting peptides have 
either lysine or arginine as the carboxy-terminal amino acid. This 
may indicate that one or both of these bonds contributes to the 
antigenic site(s) of PEP, The molecular weight of PEP was estimated 
by gel filtration to be approximately 48000 daltons. Dissociation 
with sodium dodecyl sulphate under reducing conditions resulted in a 
single immunoreactive component of about 27000 molecular weight. It 
is therefore possible that PEP is a dimer. No evidence was found of 
immunological identity between PEP and any of the following proteins: 
transferrin, ceruloplasmin, a^-antitrypsin, ferritin, uteroglobin, 
alpha fetoprotein, human chorionic gonadotrophin, pregnancy-associated 
plasma proteins A and C, or pregnancy-zone protein. In addition, 
antiserum raised in rabbit against PEP failed to react against the 
decidual cytosols of pregnant baboons or pseudo-pregnant rats.
Progestagen-dependent endometrial protein is similar to 
alpha uterine protein in several respects. Firstly, both proteins are 
thought to be uterine-specific, although the complete tissue distribution 
is not yet known for either protein. In addition, PEP and AUP are 
similar as regards molecular size and subunit structure. It therefore 
appears likely that AUP and PEP are the same protein, and investigations 
into this possibility are reported in this thesis.
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Fig. 1 (Adapted from Sutcliffe ^  j 1978). The concentration
of AUP in separate samples of human amniotic fluid obtained from
normal pregnancies during the 2nd and 3rd trimesters. AUP was
measured in samples of amniotic fluid (2-10 yl) by one-dimensional
AACE. The area under each precipitin peak was measured and the
2
concentration of AUP expressed in units of area (mm ) per ml 
amniotic fluid. Internal standards were run simultaneously on 
each AACE plate to control for the reproducibility of the assay.
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Aims of project
The overall purpose of this research was to further study
and characterise the protein known as alpha uterine protein (AUP),
The individual aims pursued during this project were as follows:
1) To compare by biochemical and immunological means AUP from the two
major sources known, namely uterine decidua and amniotic fluid.
2) To establish more fully the tissue distribution of AUP,
3) To determine whether levels of AUP in uterine decidua vary during 
gestation in a similar manner to levels in amniotic fluid.
4) To purify AUP from amniotic fluid since this is a more-readily
available source of AUP than uterine decidua,
5) To investigate the source of AUP in amniotic fluid,
6) To determine whether AUP is the same protein as that known as
"progestagen-dependent endometrial protein" (PEP) (Joshi e_t al, 
1980a,b),
7) To attempt to establish the biological function of AUP.
MATERIALS AND METHODS
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Chemicals
Bovine serum albumin, ovalbumin^ (3-lactoglobulin, myoglobin, 
carbonic anhydrase. Blue dextran, hydrocortisone (cortisol), Goomassie 
Brilliant Blue R stain, agarose (Type 1. Low electro-endosmosis), 
2-mercaptoethanol and Trizma base (Tris) were obtained from the Sigma 
Chemical Company. In the preparation of gels and buffers chemicals 
of analar grade were used. Most of these chemicals were obtained 
from either BDH Chemicals Ltd., or Hopkins and Williams.
Antisera
Monospecific rabbit antisera to Human Albumin, Gc-globulin 
and a anti trypsin were obtained from Behringwerke AG, Marburg, W. 
Germany. Sheep antiserum to whole human serum proteins was previously 
raised in this laboratory. Rabbit antisera to AUP from two separate 
sources, amniotic fluid and uterine decidua were available in the 
laboratory. The antiserum to amniotic fluid AUP was produced in this 
laboratory. Rabbits were injected with unadsorbed protein from human 
amniotic fluid which had been subjected to "negative antibody affinity 
chromatography" in order to remove the major serum proteins and alpha 
fetoprotein, as described by Sutcliffe ejt ^  (1978). This antiserum 
was rendered monospecific to AUP by adsorption with adult human serum 
and adult liver homogenate. The antiserum to decidual AUP was produced 
by the Radiochemical Centre, Amersham. This antiserum was raised 
against AUP partially-purified in this laboratory from 11 week gestation 
human decidua. The purification procedure consisted of antibody 
affinity chromatography followed by ion exchange chromatography, as 
described by Sutcliffe et al (1980), However, the final gel
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filtration step was omitted. Instead, AUP was isolated on non­
denaturing polyacrylamide tube gels and subsequently eluted from the 
gels. This material was used to immunise a total of three rabbits.
Adsorption of anti-AUP serum
Unless otherwise stated, anti-AUP serum was routinely 
adsorbed with adult human serum before use, in order to remove serum 
specificities. Adsorption was performed in the solid phase using a 
glutaraldehyde polymer immunoadsorbent, according to the method of 
Avrameas and Ternynck (1969), The immunoadsorbent was prepared as 
follows: 25% glutaraldehyde was added to undialysed adult human serum,
in a ratio of 1 to 50 (v/v). The serum was placed in a small beaker 
and the glutaraldehyde added dropwise, with stirring. An insoluble 
gel formed within 5-10 minutes. This was left overnight at room 
temperature then homogenised in phosphate-buffered saline (PBS) in an 
MSE blender for several minutes. This was followed by centrifugation 
at 5K for 10 minutes in a refrigerated centrifuge (Sorvall RC-2,
Du-Pont Instruments), The protein concentration in the supernatant 
was measured spectrophotometrically (optical density at 280 nm) to 
test the degree of protein insolubilization, (Under these conditions, 
most of the protein should be insolubilized, hence there should be a 
low protein concentration in the supernatant.) The supernatant was 
then discarded. The insoluble pellet was pressed through a metal 
sieve into a large beaker and dispersed in PBS, The resultant polymer 
was stirred on a mechanical mixer until it resembled "fines". It was 
then allowed to settle and the supernatant decanted off. The polymer 
was then stored at 4°C until use. Term cord serum-glutaraldehyde
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polymer was produced in the same way, using a 50:1 ratio of undialysed 
term cord serum to 25% glutaraldehyde instead of adult human serum.
Use of glutaraldehyde polymer immunoadsorbents: A volume of polymer
approximately twice that of the antiserum to be adsorbed was placed in 
a test tube and packed by high speed centrifugation for about 2 minutes 
using a bench centrifuge. The supernatant was discarded and the 
antiserum pipetted on to the polymer. The contents of the test tube 
were thoroughly mixed using a Whirlimixer then agitated overnight at 
room temperature on an orbital shaker to allow adsorption to occur.
The polymer was subsequently separated from the adsorbed antiserum by 
centrifugation.
Homogenisation of Tissues
Homogenates of decidual and placental tissue were prepared. 
The excised pieces of tissue were rinsed with PBS to remove blood clots 
and extraneous proteins then blotted dry. All tissue samples were 
homogenised in an equivalent volume of PBS. Small pieces of tissues 
were homogenised by hand in a glass vessel with a ground glass plunger. 
Larger tissue samples were homogenised in an MSE blender. The 
resultant homogenates were centrifuged at 13K for 15 minutes in the 
Sorvall refrigerated centrifuge. The supernatant was then filtered 
through Whatman No. 1 paper to remove any surface lipids. A clear 
homogenate was thus obtained.
Estimation of protein concentration
This was performed according to the spectrophotometric method 
described by Lowry e_t sd (1951). A calibration graph was first
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constructed using increasing volumes (20, 50, 80 and 100 pi) of bovine 
serum albumin, of protein concentration 1 mg/ml as the reference 
standard. The protein concentration in each sample assayed was then 
calculated as the mean of three determinations performed using 
different sample volumes.
Buffers
10 mM phosphate buffers : These were prepared by adding 10 ml of
solutions of 1 M potassium dihydrogen orthophosphate (KH^PO^) and 1 M 
di-potassium hydrogen orthophosphate tri-hydrate (K^HPO^, SH^O) per 
litre of distilled water. The ratio of the volumes of 1 M KHgPO^ and 
1 M K^HPO^jSH^O varied according to the pH of the buffer required,
10 mM phosphate buffers containing sodium chloride at 50 mM-0,5 M 
concentrations were prepared in the same way. In these buffers 
adjustments of pH were made by the addition of HCl or NaOH, as required.
2M potassium iodide, 50 mM Tris, pH 8.0 (for antibody affinity 
chromatography).
332 g KI
6.05 g Tris]
In 1 litre of phosphate buffered saline 
To pH 8.0 with HCl
Page^acetate buffer (for Con-A Sepharose chromatography)
0.1 M sodium acetate 16.406 g
1.0 M sodium chloride 116,88 g
1.0 mM calcium chloride 0,22198 g
1.0 mM manganous chloride 0,39582 g
1.0 mM magnesium chloride 0.40666 g
In 2 litres of distilled water. To pH 6.0 with HCl.
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Barbitone Immunoelectrophoresis buffers
1 X conc. Tank buffer 2 X conc. Gel
Barbitone 13.8 g 11.07 g
Sodium barbitone 87,6 g 70.07 g
Calcium lactate 3.84 g 10.24 g
Merthiolate (thiomersal) 2.0 g ^/5000 *
Tris 121.1 g -
Volume 10 L 5 L
pH 8.6 8.6
if Use 1 L, of 1:1000 merthiolate per 5 L. gel buffer.
Immunological Techniques
Antibody-antigen crossed electrophoresis (AACE) was carried 
out on 17o agarose gel according to the methods of Laurell (1965, 1966) 
and Clarke and Freeman (1968), Ouchterlony double immunodiffusion was 
also performed on 1% agarose gel, as described by Ouchterlony and 
Nilsson (1978).
Preparation of 1% agarose gel plates; Agarose was prepared by auto- 
claving 1 g agarose with 50 ml distilled water. While the agarose was 
still molten, 50 ml of 2 x concentrated gel buffer was added and 
thoroughly mixed. During use, bottles of agarose were placed in a 
water bath at 50-60°C to retain the molten state. Both AACE and 
double immunodiffusion were carried out on glass plates approximately 
8 cm square which hold 10 ml gel. Molten agarose was pipetted on to 
the plates to form an even layer, and allowed to solidify. The best 
results were obtained if the poured plates were left in a humidity 
cabinet for several hours before use, to allow the gel to set completely,
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One-dimensional AACE: A horizontal strip of gel was removed from
the gel plate and replaced by a mixture of molten agarose and antiserum 
to form the antibody bed* Antiserum concentrations of up to 20% by 
volume may be added to the molten gel, A series of wells were then 
cut in the gel under the antibody bed and small volumes (generally 
2-10 pi) of the antigens introduced into each well using a Hamilton 
microlitre syringe. Electrophoresis was then carried out in a perspex 
tank containing Barbitone tank buffer, pH 8,6, such that the antigens 
migrated across the antibody bed towards the anode. Electrophoresis 
was performed overnight at 4^0 at a constant current of 3 mA/plate,
Two-dimensional AACE: In this technique, proteins are separated
according to charge in the first dimension then electrophoresed into an 
antibody bed. Therefore it may be used to separate the components in 
a complex mixture of antigens or to establish the electrophoretic 
mobility of a single antigen. The antigen was introduced into a well 
cut at one side of the gel and electrophoresed in the anodal direction 
at a constant voltage of approximately 20 mV/cm to form the first 
dimension. Electrophoresis in the first dimension generally took 
about 3 hours. The migration of the antigen in question was monitored 
relative to that of albumin which has a greater mobility than that of 
most serum proteins. The addition of tincture of merthiolate, which 
contains an orange dye to the gel enables albumin to be easily located. 
Albumin binds to this dye and is visualised as a pink spot. This was 
marked by a small circle cut into the gel using the tip of a Pasteur 
pipette. After the first dimension electrophoresis was completed, 
an antibody bed was poured parallel to the protein track. The plate 
was then rotated 90° such that the antigen(s) was electrophoresed into
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the antibody bed. This second dimension was run more slowly at a 
constant current of 3 mA/plate, overnight,
Ouchterlony double immunodiffusion: This was performed according to
the method of Ouchterlony and Nilsson (1978), Circular wells of 4 mm 
diameter were cut in 1% agarose plates and solutions of antisera and 
antigens introduced into separate wells. The wells were generally 
spaced about 8 mm apart (centre to centre), but the spacing varied 
according to the concentrations of the reagents used. The plates 
were left in a humidity cabinet for 24-48 hours to allow immunodiffusion 
to occur. Lines of precipitation mark the formation of immune 
complexes. These were sometimes visualised without staining as white 
lines on the gel.
Both AACE and Ouchterlony plates were washed individually in 
10% PBS for approximately 24 hours, with several changes. During washing 
the buffer was circulated using an air pump. This caused the gel sheet 
to detach from the glass plate thus enabling washing of both sides of 
the gel. After washing, each gel was carefully replaced on its glass 
plate and a sheet of blotting paper placed on top. The plates were 
then dried in air. The blotting paper prevented shrinkage of the gel 
from the edges of the glass plate. The gels were then stained with 
2% Coomassie Brilliant Blue. This stain consists of 2% Coomassie 
Brilliant Blue R Stain (w/v), 50% Methanol (v/v) and 7% acetic acid (v/v). 
Finally, the gels were destained in 50% Methanol (v/v), 7% acetic acid 
(v/v). Immune-complexes were visualised as blue-coloured precipitin 
arcs.
Quantitation of proteins by one-dimensional AACE
The concentration of a given protein may be measured by 1 D
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AACE using an antiserum specific to this protein. In this technique, 
various volumes of the antigen in question are applied to a 1 D AACE 
plate and electrophoresis performed as described in the preceding 
section, A reference standard containing a known concentration of 
the protein to be measured is run alongside the unknown sample (prefer­
ably on the same AACE plate). The areas under the resultant precipitin
peaks are then measured. From a graphical expression of volume applied
2
(|i.l) versus area enclosed by the peaks (mm ), the concentration of the 
protein in the unknown sample can be calculated relative to .that in the 
reference standard.
Worked example: The concentration of anti trypsin in a sample of human
amniotic fluid was measured relative to that in human serum (Protein- 
Standard- Serum LC-V, Behringwerke AG, Marburg, W, Germany), The latter 
was used as a reference standard because it is known to contain 0,13 
mg/ml a^-antitrypsin. Fig 2(a) shows the 1 D AACE quantitation plate: 
the five wells on the right hand side of the plate contain different 
volumes of the serum standard and the five wells on the left hand side 
corresponding volumes of amniotic fluid. The areas under the precipitin 
peaks are tabulated in Fig 2. These results are expressed graphically 
in Fig 2(b). The concentration of a^-AT in amniotic fluid can be 
directly compared to that in human serum by comparing the slopes of the 
lines on the graph. This gives a value of 2.32, Hence, the 
concentration of a^-AT in the amniotic fluid sample is 2.32 times that in 
the standard serum sample. Therefore the concentration of a^-AT in the 
amniotic fluid sample is 2,32 x 0,13 - 0.30 mg/ml. Note that in the 
case of AUP quantitations by 1 D AACE no reference standard of known AUP 
concentration was available. Therefore levels of AUP in unknown samples
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were compared with those in an arbitrary standard which was said to 
contain 1 "unit" of AUP per ml. The results were thus expressed as 
"units" AUP/ml or "units" AUP/mg protein,
SDS-polyacrylamide gel electrophoresis
4.5-12.5% gradient SDS-polyacrylamide slab gel electrophoresis 
was kindly carried out by Mr. J, Hunter according to the method of 
Laemmli (1970), Details of the reagents, buffers and gel composition 
are outlined in Table 1. In pouring the slab gel the bottom of the gel was 
sealed with a layer of 12.5% running gel to a depth of approximately 1.5 cm. 
This was allowed to set, then the 4.5-12.5% gradient running gel poured.
The depth of this layer was approximately 13 cm. This was allowed to 
set as before, then the final layer of 4,5% spacer gel poured to a depth 
of about 2.5 cm. The loading comb was inserted before the gel set then 
removed when setting had occurred. Preparation of the samples run on the 
gel is described in the "Results" section. The gel was run at 30-35 jj.A 
without cooling for approximately 5 hours, followed by 4 hours at 40-45 
pA, during which time the gel was air-cooled using an electric fan.
Binding Theory and Scatchard Plot
Scatchard analysis was carried out as described by Rosenthal 
(1967). This is outlined below:
Binding Theory
(b) = concentration of ligand bound to macromolecule
(u) = concentration of free ligand
(M) = concentration of macromolecule
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n = number of binding sites (this can only be calculated if
using a protein preparation of known molecular weight) 
k = intrinsic association constant
(1) k = (b)______________________ __________
(u) X conc, .of free binding sites
—  = k X conc, of free binding sites
(3) Conc, of free binding sites = conc, of available binding sites - 
conc. of occupied binding sites.
(4) Therefore, ^  . k (n. (M) - (b) )
Scatchard plot. Equation (4) is obtained by plotting against (b)
which gives a straight line with a slope of -k, an intercept on the 
ordinate of k.n,(M) and an intercept on the abscissa of n,(M), where 
n,(M) - conc. of binding sites. Therefore, if (M) is known, n can 
be calculated. The Scatchard Plot obtained from this equation is 
illustrated in Fig. 3.
NB/ If a curved line is obtained on the graph, this represents the 
sum of two classes of binding: specific (initial steep descent of
curve ie high affinity binding) and non-specific (low affinity binding). 
This may reflect the presence of a single macromolecule with more than
one group of binding sites or two or more macromolecules with differing
binding affinities.
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Fig 2. Quantitation of «^-antitrypsin in human amniotic fluid 
by one-dimensional AACE.
a) One-dimensional AACE quantitation plate comparing 
the concentration of «^-antitrypsin in human 
amniotic fluid and standard human serum. The 
antiserum was monospecific rabbit antiserum to human 
«^-antitrypsin, used at a final concentration of 4%,
The antigens were as follows:
Wells 1-5 : Human amniotic fluid (2,4,6,8,10 pi)
Wells 6-10 : Standard human serum (2,4,6,8,10 pi).
Areas under the precipitin peaks
2
Volume applied (pi) Area under peak (mm )
Amniotic fluid Standard serum
2 12 3
4 19 7
6 28 10
8 34 17
10 45 20
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Fig. 2(b) Graph of areas under precipitin peaks against
volume applied on AACE.
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Table 1. Reagents, buffers and gels used in 4.5-12.5% gradient 
SDS-polyacrylamide gel electrophoresis.
Reagents ; 30 g acrylamide ) to 100 ml with distilled water
0,8 g Bis acrylamide)
10% ammonium persulphate (freshly-prepared)
Temed
Glycerol : water ( 1 + 1  solution)
Buffers :
Running gel buffer 18,15 g Tris ) 
)
0.4 g SDS )
to loo ml with distilled water 
Adjusted to pH 8,9 with HCl.
Spacer gel buffer : 5.9 g Tris ) 
)
0.4 g SDS )
to loo ml with distilled water 
Adjusted to pH 6,7 with HCl.
Tank buffer ; 6,3 g Tris ) 
)
4.0 g glycine)
)
1.0 g SDS )
to 1 L, with distilled water
4.5-12.5% gradient gel
Reagent
Acrylamide
Running or Spacer gel buffer 
Glycerol ( 1 + 1  soln) 
Distilled H^O 
Temed
10% Ammonium persulphate
4.5% gel 
3.6 ml 
6.0 ml
14,4 ml 
20 111 
. 0.1 ml.
12.5% gel 
10 ml 
6.0 ml 
7.2 ml 
0.6 ml 
20 III 
0,1 ml
Total volume approx 24 ml 24 ml
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RESULTS
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1, Comparison of AUP from uterine decidua and amniotic fluid 
Introduction
Although AUP was first Isolated from amniotic fluid (Sutcliffe 
et al) 1978), it was subsequently purified from uterine decidua and the 
initial physicochemical characterisation was based on this decidual AUP 
(Sutcliffe et al, 1980), Evidence was also presented of immunological
and electrophoretic identity between AUP from these two major sources 
(Sutcliffe et al, 1980), However, to date this evidence remains un­
confirmed, Therefore, in an attempt to substantiate these findings,
AUP from uterine decidua and amniotic fluid was compared as regards 
molecular size, electrophoretic mobility and immunological cross-reactivity,
a) Determination of the molecular weight of amniotic fluid AUP
Methods : A 3,5 x 90 cm column of Sephadex G-150 (Pharmacia) was
calibrated by applying the following pure proteins of known molecular 
weight as reference standards: bovine serum albumin, ovalbumin, (3-lacto-
globulin and myoglobin. Fractions were collected after each run of the 
column and the elution volumes (Ve) estimated by spectrophotometry 
(absorbance at OD280). The void volume (Vo) was estimated by applying 
Blue dextran to the column. This has a molecular weight of 2 x 10^ 
which is above the exclusion limit of the gel. A calibration curve was 
then drawn from a graph of (Ve-Vo) versus log MW, A 50 ml sample of 
amniotic fluid (pooled fluids of 14-16 weeks* gestation) was dialysed 
against 10% PBS then lyophilised in an Edwards Modulyo Freeze-drier 
and resuspended in 5 ml distilled water. The final protein concen­
tration in the amniotic fluid sample was 11,5 mg/ml. After centrifu­
gation, the supernatant was applied to the column and fractions collected
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as before. The presence of AUP in the fractions was detected by one­
dimensional AACE using two different antisera: raised in rabbit against
amniotic fluid AUP and decidual AUP, respectively. The elution volume 
of AUP was estimated from the fractions which produced the highest 
precipitin peaks on ID AACE.
(see main "Materials and Methods" section for further details.)
Results : The molecular weights and elution volumes of the proteins
used to establish the calibration curve and the elution volume of AUP 
are shown in Table 2. The elution curve of myoglobin, one of the 
reference standards, is illustrated in Fig 4, The amniotic fluid 
fractions which contained AUP were detected by one-dimensional AACE.
The same peak fractions were observed using antisera raised against 
either decidual or amniotic fluid AUP, Fig 5 shows the peak AUP 
fractions as visualised on one-dimensional AACE, An elution volume 
of 303.3 ml was measured for AUP, When the Ve-Vo (AUP) was plotted 
on the calibration curve, it was found to correspond to a molecular 
weight of 53,700 (see Fig 6),
b) Comparison of decidual and amniotic fluid AUP as regards electro­
phoretic mobility and immunological cross-reactivity
Methods : The electrophoretic mobilities of AUP from these two sources
were examined by two-dimensional AACE, Immunological cross-reactivity
was tested using two different methods: Ouchterlony double immunodiffusion 
and tandem-crossed electrophoresis. In the latter technique, the two 
antigens to be tested for cross-reactivity, in this case amniotic fluid 
and decidua are run simultaneously on two-dimensional AACE, The two 
antigens are spaced about 8 mm apart horizontally and electrophoresed
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in the first dimension. If the antigens are identical they will have 
the same electrophoretic mobility, but due to the horizontal spacing 
one will "lag behind" the other. The plate is then turned 90° and the 
second dimension electrophoresis carried out as described previously.
If the two antigens cross-react completely the resultant precipitin 
peaks will be continuous. However, two overlapping peaks will indicate 
either partial identity or non-identity between the antigens, depending 
on the degree of overlap, (see main "Materials and Methods" section 
for further details.)
Results : AUP from the two sources examined gave single peaks of
identical mobility (see Fig 7). Peak morphology was similar in each 
case, in that a somewhat "skew" shape was observed. On Ouchterlony 
double immunodiffusion a reaction of complete identity was observed 
between the antisera raised against AUP from uterine decidua and amniotic 
fluid (see Fig 8), In addition, a precipitin peak with a continuous 
"shoulder" was observed on tandem-crossed electrophoresis, indicating 
complete identity between AUP from these two sources (see Fig 9),
Discussion; AUP from uterine decidua and amniotic fluid was found 
to have the same electrophoretic mobility on two-dimensional AACE and 
to be immunologically identical. This supports the previous findings 
of Sutcliffe _et £l (1980). In addition, the molecular weight of AUP 
of amniotic fluid origin was estimated by gel filtration on Sephadex 
G-150 (Pharmacia) to be approximately 53,700 daltons. This compares 
favourably with the MW of 50,000 previously found for decidual AUP by 
the same method (Sutcliffe et al, 1980), Thus, it appears likely that 
AUP from these two major sources is antigenically and structurally
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identical. However, unequivocal evidence of identity between AUP from 
amniotic fluid and decidua awaits a detailed comparison of the physico­
chemical characteristics of the pure protein from each source. This 
cannot be carried out at this stage because to date AUP has only been 
purified from human uterine decidua (Sutcliffe et al, 1980), However, 
efforts will be made during the course of this research project to 
purify AUP from human amniotic fluid, (see Results 6. "The partial 
purification of AUP from amniotic fluid,")
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Table 2. The elution volumes of molecular weight standards and AUP 
after gel filtration on Sephadex G-150
Standard Molecular
weight
Elution vol (ml) 
(Ve)
Elution vol - 
Void vol (ml) 
(Ve-Vo)
Blue dextran 2 X 10^ 201.8 0
BSA 68000 282 80.2
Ovalbumin 43000 308.5 106.7
P-Lactoglobulin 36726 332 130.2
Myoglobin 16951 369.5 167.7
AUP - 303.3 101,5
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Fig. 4. Elution curve of Myoglobin after gel filtration on
Sephadex G-150. The elution volume (Ve) is indicated 
by a broken line.
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Fig. 5. One-dimensional AACE of peak AUP fractions eluted after
gel filtration of amniotic fluid on Sephadex G-150, The antiserum 
was raised against decidual AUP and adsorbed with adult male human 
serum. It was used at a final concentration of 10%. 10 |il
volumes of each fraction were applied to separate antigen wells.
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Fig. 6 . Estimation of the molecular weight of AUP from a
calibration graph of elution volume against Log MW
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Fig. 7. Two-dimensional AACE comparing the electrophoretic mobilities 
of decidual and amniotic fluid AUP, The antiserum was raised against 
decidual AUP and adsorbed with adult male human serum. The final 
antiserum concentration was 20%. The antigens were inserted in wells 
on the left hand side of the plate and electrophoresed towards the 
anode (L - R) to form the first dimension. In the second dimension, 
each antigen was electrophoresed into a separate antibody bed.
The antigens were as follows:
Upper well: 5 |j.l of 11 week gestation decidua (1.8 mg/ml total protein)
Lower well: 5 p.1 of 14-16 week gestation amniotic fluid, pooled from
various patients (2.3 mg/ml total protein).
The single circles at the RHS of the plate indicate albumin mobility 
in the first dimension.
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Fig. 8. Ouchterlony double immunodiffusion experiment illustrating 
serological identity between AUP from decidua and amniotic fluid. The 
wells are 4 mm in diameter. The contents of the wells are as follows:
1. rabbit antiserum to amniotic fluid AUP, adsorbed with adult human 
serum (10 (il).
2. homogenate of 11 week decidua at protein concentration of 0.18 mg/ml 
(10 nD.
3. rabbit antierum to decidual AUP, adsorbed with adult human serum (10 |il)
4. 14-16 week amniotic fluid at protein concentration of 2.3 mg/ml (10 |il).
Fig. 9. Tandem-crossed electrophoresis of decidual and amniotic fluid 
AUP. The antiserum was raised against decidual AUP and adsorbed with 
adult human serum. The final antiserum concentration was 10%. The 
antigen wells are at the LHS of the plate. The well farthest to the 
left contains 2 p.1 of homogenate of 11 week decidua at protein concen­
tration of 1.8 mg/ml. The other well contains 2 p.1 of 14-16 week 
amniotic fluid at protein concentration of 2.3 mg/ml.
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2. Peak morphology of AUP on antibody-antigen crossed electrophoresis
Introduction: As mentioned in the preceding section, AUP produces a
precipitin peak which is rather "skew*' in shape on two-dimensional AACE, 
Another characteristic feature of the AUP peak on AACE is that it 
appears to be "filled-in" or solid, ie, in addition to the usual deeply- 
staining outline of precipitated antibody/antigen complexes the area 
enclosed by this peak is also more deeply-staining than the surrounding 
antibody bed. Several experiments were devised to investigate this 
phenomenon.
Methods : Using the technique of one-dimensional AACE, experiments
were carried out to investigate whether any of the following variables 
resulted in an alteration of the characteristic AUP peak morphology:
(i) a range of antiserum concentrations from 4% to 20%.
(ii) a range of antigen concentrations from approximately 0.02-14.0 
mg/ml total protein,
(iii) different sources of AUP: decidua, amniotic fluid and early 
gestation placenta,
(iv) antisera raised against AUP from different sources, namely 
decidua and amniotic fluid.
Results : The production of "filled-in" AUP peaks was not affected
by the concentration of the antiserum or by the concentration or volume 
of the antigen. In addition, all three sources of AUP tested, namely 
decidua, amniotic fluid and early gestation placenta resulted in the 
production of such peaks. However, these peaks were only observed 
when AUP was reacted against antiserum raised against decidual AUP of 
which a total of 3 were available. When tested with the two available
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antisera to amniotic fluid AUP, normal "hollow" peaks were observed 
(see Fig 10).
Discussion; The production of the characteristic "filled-in" AUP 
peak on AACE does not appear to reflect either antibody or antigen 
excess since varying the concentrations of each reagent had no effect 
on peak morphology. The results of these experiments suggest that 
this unusual peak morphology is a feature of antibody-antigen 
specificity since it occurs only with antisera raised against decidual 
AUP. This may indicate that, contrary to previous findings, the 
decidual and amniotic fluid forms of AUP may not be antigenically 
identical. However, the exact nature of this effect is not known.
62
i  i
Fig. 10. One-dimensional AACE illustrating the different AUP peak
morphologies obtained using antisera raised against AUP from the two 
major sources.
RHS. Antiserum to amniotic fluid AUP, adsorbed with adult human 
serum. Final antiserum concentration 207.. Antigens (L - R) ;
11 week gestation decidua, at protein concentration of 0.9 mg/ml (5 |il), 
amniotic fluid at protein concentration of 2.3 mg/ml (5 pi).
LHS. Antiserum to decidual AUP, adsorbed with adult human serum.
Final antiserum concentration 10%. Antigens (L - R): amniotic
fluid at protein concentration of 2.3 mg/ml (5 pi, 6 pi).
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3, The interaction between AUP and a component of Term cord serum
Introduction; Term cord serum is obtained from the umbilical cord 
at delivery, hence is of fetal origin, AUP cannot be detected in term 
cord serum (TCS) by the standard one-dimensional AACE method. However, 
it was noticed during routine AACE experiments checking the specificity 
of antisera raised against AUP that a combination of amniotic fluid 
and TCS resulted in the production of an AUP precipitin peak which was 
substantially higher than that produced by amniotic fluid alone. This 
effect was only observed with antiserum raised against decidual AUP 
from one particular rabbit, designated "AÜP3", This finding suggests 
that there is a component in TCS which has one or more antigenic 
determinants in common with AUP, or may be a different protein which 
shares a subunit with AUP, Several experiments were carried out to 
further investigate this phenomenon. The aims of these experiments were 
as follows: a) To discover whether or not the observed effect of TCS
was reproducible. b) To find if. there was a similar interaction between 
TCS and AUP of decidual origin. c) To investigate the possibility of 
immunological cross-reactivity between the TCS-component and AUP, 
d) To investigate whether this "AUP-like" component was purely of fetal 
origin.
Methods t One-dimensional AACE and double immunodiffusion were
carried out as described in the main "Materials and Methods" section.
Results ; a) The observed effect of the addition of TCS to amniotic
fluid on one-dimensional AACE resulting in an increased AUP peak height 
relative to that produced by amniotic fluid AUP alone was found to be
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reproducible, using the same anti-AUP serum as before. This effect is 
illustrated in Fig 11,
b) When a combination of TCS and decidua of 11 weeks' gestation was 
reacted against "AUP3" antiserum on ID AACE no increase in peak height 
relative to that produced by decidual AUP alone was observed,
c) A double immunodiffusion experiment was carried out to investigate 
whether there was any evidence of immunological cross-reactivity 
between AUP from amniotic fluid and the TCS-component. The wells 
containing TCS and amniotic fluid were placed in close proximity to 
determine if TCS interferes in any way with the interaction between 
amniotic fluid AUP and the specific antiserum. The result of this 
experiment is shown in Fig 12. The AUP precipitin arc extends some 
distance into the zone of diffusion of TCS. However, it is not clear 
whether this represents diffusion of AUP from the adjacent amniotic 
fluid well, or an interaction, between the TCS-component and anti-AUP 
serum. Another immunodiffusion experiment was carried out to 
distinguish between these two possibilities. The wells were arranged 
as shown in Fig 13, If the observed result (Fig 12) was due to 
diffusion of AUP from the adjacent amniotic fluid well, the AUP 
precipitin line should extend an equal distance on either side of the 
line bisecting the amniotic fluid well (precipitin line a in Fig 13).
If there is an interaction between the TCS-component and AUP, however, 
the precipitin line should curve round in the region of TCS diffusion 
(precipitin line b in Fig 13), The former result was observed (see 
Fig 14), indicating that there is no evidence of immunological cross­
reactivity between AUP and the TCS-component on double immunodiffusion.
d) Adsorption of the "AUP3" antiserum with human term cord serum 
resulted in the disappearance of the TCS-component which interacted with
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AUP on ID AACE. However, there was no evidence of a similar component 
in any of the following fetal tissues, as investigated by ID AA.CE: 
homogenates of fetal liver, kidney, heart, gut or skin, or fetal red 
cell lysates. As a further control for fetal specificity, maternal 
serum was combined with amniotic fluid and reacted against the "AUP3" 
antiserum on ID AACE, However, the addition of maternal serum of 
between 9 and 41 weeks' gestation to amniotic fluid failed to produce 
peaks taller than those of AUP alone.
Discussion; The "AUP-like" component in TCS appears to be of fetal 
rather than maternal serum origin, and may be exclusive to TCS, The 
increased peak height on AACE resulting from the addition of TCS to 
amniotic fluid AUP may reflect either; (i) the attachment of the 
"AUP-like" component in TCS to the periphery of the existing AUP/anti- 
AÜP insoluble complex, or (ii) the formation of soluble immunocomplexes 
between the TCS-component and anti-AUP antibodies, thereby reducing 
the number of antibodies available to react with AUP. This would 
result in a local decrease in antibody concentration, hence an 
increased peak height. As stated in the introduction, the "AUP-like" 
component in TCS may have one or more antigenic determinants in common 
with AUP, or may be a different protein which shares a subunit with 
AUP, This being the case, it is unclear why this component should 
interact with amniotic fluid AUP but not with AUP of decidual origin, 
particularly as the antiserum used to detect it was raised against AUP 
from the latter source.
Footnote: No further investigations could be done on the "AUP-like"
component in TCS because the particular antiserum used to detect it, 
ie, "AUP3" aged, and previous results could no longer be reproduced.
In addition, rabbit AUP3 subsequently died, so no further stocks of 
this antiserum were available.
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Fig. 11. One-dimensional AACE illustrating the effect of the
addition of term cord serum to amniotic fluid AUP, The antiserum 
was raised against decidual AUP and obtained from rabbit "AUP 3", 
It was used in the native state at a final concentration of 20%. 
The antigens were as follows (L - R); 14-16 week amniotic fluid,
at protein concentration of 2,3 mg/ml (5 (il), adult human serum 
(5 (il), amniotic fluid and adult human serum (5 + 3 (J,l), term 
cord serum (5 (il), amniotic fluid and TCS (5 + 3 (il).
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Fig. 12. Double immunodiffusion experiment illustrating a possible
interaction between AUP and the TCS-component, The central 
well contained 12 (xl of "AUP 3" antiserum, used in the native
state. The contents of the other wells were as follows;
Wells 1,3,5,6, 14-16 week amniotic fluid, at protein concen­
tration of 2,3 mg/ml (10 jil).
Wells 2,4, Term cord serum (10 pi).
Fig. 13, Diagram of arrangement of wells in double immunodiffusion
experiment investigating the possible interaction between AUP 
and an "AUP-like" component in TCS, and the possible outcomes 
of this experiment.
Fig, 14, Double immunodiffusion experiment illustrating the lack of
cross-reactivity between AUP and the "AUP-like" component in 
TCS, The central well contained 12 pi of "AUP 3" antiserum 
(native). The other wells contained the following;
Wells 1,5, 14-16 week amniotic fluid, at protein concentration 
of 2,3 mg/ml (10 pi).
Wells 2,4. TCS (10 pi).
Wells 3,6, Phosphate-buffered saline (10 pi).
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4. The distribution of AUP in human adult and fetal tissues
Introduction: AUP has been detected in human endometrium, myo­
metrium, decidua, amnion, chorion and amniotic fluid by AACE (Sutcliffe 
et al, 1978), It could not be detected in maternal serum, adult liver, 
gut, kidney, lung or skin using the same method (Sutcliffe et al, 1978,
1979), It is not yet known whether AUP is present in any fetal 
tissues. The possible presence of this protein in the fetus is of 
particular interest because AUP is present in the fetal membranes and 
an "AUP-like" component has been detected in term cord serum which is 
mainly of fetal origin. Therefore, the distribution of AUP in various fetal 
tissue homogenates was investigated.
Methods ; The following tissues were investigated for the presence
of AUP by one-dimensional AACE using antisera raised against either 
decidual or amniotic fluid AUP: homogenates of early gestation (8-13
weeks) placenta, term placenta, fetal gut, liver, skin, heart and 15-28 
week fetal red cell lysates. Preparation of the placental homogenates 
is described in the following section. The homogenates of the fetal 
tissues and the fetal red cell lysates were previously prepared in this 
laboratory.
Results : AUP was detected by one-dimensional AACE in early
gestation and term placentae, and in 17 week fetal gut (see Figs 15-17).
In one assay, trace amounts of AUP were detected in fetal skin, but 
this observation could not be repeated.
Discussion: Using the technique of antibody-antigen crossed electro­
phoresis, AUP has now been detected in the following tissues: human 
endometrium, myometrium, decidua, amnion, chorion, amniotic fluid.
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8-13 week placenta, term placenta, mid-gestation fetal gut and possibly 
fetal skin. Due to the difficulty of obtaining fetal material it is 
not known whether AUP is present in fetal gut at other stages of 
gestation. Similarly, placental material from 13 weeks of gestation 
to term is not readily available. However, the presence of AUP in 
placentae at the beginning and end of pregnancy suggests that this 
protein may occur in placental tissue throughout gestation. It is 
important to note that AUP may also occur in other fetal and maternal 
tissues in concentrations below the limit of detection by AACE. There­
fore, in order to specify the complete tissue distribution of this 
protein a more sensitive technique eg, radioimmunoassay is required.
It is equally important to establish the site(s) of synthesis of this 
protein in order to determine the origin of AUP in amniotic fluid.
In addition, this information may help in elucidating the physiological 
function of this protein. Preliminary immunofluorescence experiments 
have been carried out to determine the possible site(s) of AUP synthesis 
in decidual and placental tissue. However, from the results of these 
studies it was apparent that the available antisera to AUP were of 
insufficiently high titre for use in immunofluorescence. Therefore, a 
repetition of these experiments awaits production of anti-AUP serum of 
high titre, which in turn is dependent upon the production of purified 
or partially-purified AUP,
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Fig. 15. One-dimensional AACE illustrating the presence of AUP
in term placenta. The antiserum was raised against amniotic fluid 
AUP and adsorbed with adult human serum. It was used at a final 
concentration of 10%.
Antigens: LHS, Homogenate of 11 week decidua, at protein
concentration of 0,9 mg/ml (5 pi),
RHS, Homogenate of term placenta, at protein 
concentration of 4,45 mg/ml (5 pi).
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Fig, 16, One-dimensional AACE of AUP detected in homogenate of fetal 
gut. The antiserum was raised against decidual AUP and 
adsorbed with adult human serum. The final antiserum 
concentration was 10%, The antigens were, from left to 
right: 14-16 week amniotic fluid, at protein concentration
of 2,3 mg/ml (5 pi), homogenate of fetal skin (5 pi), 
homogenate of 17 week fetal gut, at protein concentration of 
15 mg/ml (5 pi).
Fig, 17, Double immunodiffusion experiment illustrating immunological 
identity between AUP in uterine decidua and fetal gut. The 
wells were 1.5 mm in diameter and each contained a volume of 
2 pi. The contents of the wells were as follows :- 
Central well: anti-AUP serum, raised against decidual AUP and
adsorbed with adult human serum.
Other wells, starting at top and moving clockwise: 17 week
fetal gut (15 mg/ml), 11 week decidua (1,8 mg/ml), 17 week 
fetal gut (15 mg/ml).
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5. Quantitation of AUP in uterine decidua and placenta
Introduction; The presence of AUP in homogenates of early and late 
gestation decidua and placenta has already been demonstrated in the 
preceding section, and electrophoretic and immunological identity has 
been established between decidual and amniotic fluid AUP (see section 1 
of Results). The concentration of AUP has been measured in amniotic 
fluid between 12 weeks of gestation and term by one-dimensional AACE 
(Sutcliffe ^  al) 1978), High concentrations were found during the 
second trimester of gestation, particularly between 14 and 18 weeks.
In order to determine if the concentration of AUP in uterine decidua 
varies in a similar manner throughout gestation, levels of AUP in 
homogenates of early and late gestation decidua were measured by one­
dimensional AACE, Due to the availability of samples of early 
gestation placenta, a similar AUP quantitation was carried out in this 
tissue. The concentration of AUP was also measured by AACE in a 
total of four term placentae. Preliminary experiments were done to 
determine if the AUP detected in placenta was electrophoretically and 
immunologically identical to that in amniotic fluid and decidua.
Methods ; Early gestation (8-13 weeks) decidual and placental tissue
was obtained from suction terminations of pregnancy. Late gestation
(35-40 weeks) decidua was obtained from elective caesarian sections.
Term placentae were obtained from normal vaginal deliveries. Samples
of early gestation decidua and placenta were easily distinguished by
visual inspection. In some cases, identification was confirmed by
microscopic examination of haemalum and eosin stained tissue sections,
2
All tissue samples obtained were approximately 1-3 cm in area and 
1-3 mm thick. Each sample was washed thoroughly in PBS, blotted dry
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then homogenised in an equivalent volume of PBS (about 1-5 ml, depending 
on the size of the tissue sample). After homogenisation, each sample 
was centrifuged at 4^C (13K, 15 mins). The supernatant was drained 
off and filtered through Whatman No, 1 paper to remove lipids. Each 
homogenate was then assayed for total protein by the Lowry method.
The electrophoretic mobility of placental AUP was compared to that of 
decidual and amniotic fluid AUP by two-dimensional AACE, Immunological 
cross-reactivity of AUP from these three sources was established by 
double immunodiffusion and one-dimensional AACE, In the latter 
experiment homogenates of placenta were combined with known AUP standards 
and reacted against specific anti-AUP serum. If the height of the 
resultant precipitin peak was greater than that produced by the AUP 
standard alone, this indicated immunological identity between placental 
AUP and that present in the reference standards. The concentration of 
AUP in each tissue homogenate was measured by one-dimensional AACE, as 
described in the main "Materials and Methods" section, A homogenate 
of 11 week gestation decidua was used as the reference standard. The 
results of each quantitation were expressed as "units AUP/mg protein". 
Each quantitation was repeated, and the average AUP concentration 
determined. Due to the technical difficulties involved in homogenising 
a complete human placenta at term an alternative means of sampling from 
a wide area of this organ was sought. This was achieved by excising 
small pieces of tissue (dimensions as described above) from different 
areas of the placenta, ie. from the centre and periphery, and from the 
fetal and maternal surfaces, as illustrated below (see Fig 18), The 
tissue samples were homogenised and AUP assayed by one-dimensional 
AACE as before.
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Fig. 18. Schematic drawing of term placenta indicating 
the areas from which tissue samples were excised, A total 
of six samples of placental tissue were obtained (A-F).
Results ; The electrophoretic mobility of AUP in homogenates of
early gestation placenta, as determined by 2D AACE, compared favourably 
with that of AUP of decidual and amniotic fluid origin. This is 
illustrated in Fig 19. Immunological identity between placental AUP 
and AUP from decidua and amniotic fluid was demonstrated by double 
immunodiffusion and ID AACE, In the latter experiment, the combin­
ation of placenta and either decidua or amniotic fluid produced a 
peak which was taller than that produced by either decidua or amniotic 
fluid alone, when reacted against antiserum specific to AUP, The 
results of the quantitation of AUP in early gestation decidua and 
placenta and in late gestation decidua by ID AACE are shown in Tables 
3 and 4. Trace amounts of AUP were detectable in a total of 16 tissue 
samples of term placenta, out of the 24 samples assayed. However,
AUP was present in each of the four term placentae examined, and in all 
six regions of the placenta sampled (A-F), No correlation was found
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between the position of the tissue sample in the placenta and AUP 
concentration. In all cases, the concentration of AUP was too low to 
allow an accurate quantitation. The minimum concentration of AUP 
which can be accurately determined by one-dimensional AACE is 0,02 
units/ml. Therefore, in the homogenates of term placentae the concen­
tration of AUP was less than this amount. However, by taking into 
account the total protein concentration of each homogenate an estimate 
of AUP concentration, expressed as units AUP/mg protein was determined. 
The range and mean values of AUP concentration in the tissue samples 
from each placenta assayed are shown in Table 5,
Discussion; The results of the preliminary experiments indicate that
placental AUP is identical to that present in decidua and amniotic 
fluid as regards immunological cross-reactivity and electrophoretic 
mobility. The results of the AUP quantitation experiments raise 
several interesting points, which are outlined below:
1) Early in gestation (8-13 weeks) the range of values of AUP concen­
tration are similar in placenta and decidual tissue ie, 0.2-2,0 units/ 
mg protein and 0,4-2,8 units/mg protein, respectively. However, the 
concentration of AUP is slightly higher in decidual tissue than in 
placenta at each stage of gestation. As previously mentioned, the 
presence of AUP in both pregnant and non-pregnant uterine tissue
suggests that this is the major site of synthesis of this protein.
However, the similarity between the levels of AUP in decidual tissue 
and placenta early in gestation indicates that both tissues may 
synthesise AUP at this stage.
2) There is no apparent correlation between gestational age and AUP 
concentration in either placenta or decidual tissue between 8 and 13
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weeks of gestation. In a previous study (Sutcliffe ^  al, 1978) the
concentration of AUP was measured in amniotic fluid samples between
12 weeks of gestation and term. High levels of AUP were found between
15 and IB weeks after which there was a decline in concentration to
term (see Fig 1), However, no amniotic fluid samples of less than 12
weeks* gestational age were available. Therefore, it is impossible to
compare the amniotic fluid results with those of the present study,
3) In the case of amniotic fluid AUP levels there is a decline in
concentration of approximately ten-fold between 12 weeks' gestation and
term (Sutcliffe et al, 1978), Similarly, there is an overall decrease
in AUP concentration towards term in both decidual tissue and placenta.
However, in both tissues the decline in AUP concentration is very much
greater than that reported for amniotic fluid AUP, ie, the values of
AUP concentration in decidual tissue at delivery (see Table 4) are 
1 1
50* Too" the concentrations early in gestation (see Table 3),
whereas in placenta an even greater reduction in concentration of 
1 1
4ÔÏÏ ” 3000 found (see Tables 3 and 5),
The results of this quantitation of AUP in decidual and 
placental tissue are discussed more fully in the "General Discussion", 
with regard to the synthesis of AUP and its possible origins in 
amniotic fluid.
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Fig. 19. Two-dimensional AACE illustrating the electrophoretic 
identity of AUP from decidua and placenta. The antiserum was 
raised against decidual AUP and adsorbed with adult human serum.
The final antiserum concentration was 10%, The antigens were 
inserted in wells at the far LHS of the gel. Upper well; 10 week 
decidua, at protein concentration of 6,65 mg/ml. Lower well:
10 week placenta, at protein concentration of 32 mg/ml. The single 
circles at the RHS of the gel indicate albumin mobility in the 
1st dimension.
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Table 3. Concentration of AUP in decidual tissue and placenta
early in pregnancy.
Gestation
(weeks)
Cone, of AUP (units/mg protein) 
Decidual tissue Placenta
8 NT^ 0,2
8 2,8 NT
9 0.9 0.2
11 2.2 2.0
13^ 1.4,0.4 NT
13 0,6 0.5
a not tested
b two samples of decidua were recovered from this case and assayed
separately as shown.
Table 4* Concentration of AUP in decidual tissue at delivery
Gestational
period
No. of AUP cone, (units/mg protein)
(weeks) patients Range Mean
35-37 3 0 ,01-0,02 0,015
38-39 7 0.0025-0.085 0,027
40 4 0.004-0.01 0,0065
Table 5, Concentration of AUP in placental tissue at delivery
Gestational
period
(weeks)
^No, of tissue AUP cone (units/mg protein x 10 ^)
per placenta Range Mean
unknown 6 5,48-8,66 6.58
38 1 - 6,06
39 5 4.13-6.08 5,12
40 4 4,53-6,92 5,68
c this denotes the number of s.amples in which AUP was detectable by
one-dimensional AACE, out of a total of 6 tissue samples assayed
per placenta.
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6, The partial purification of AUP from amniotic fluid
Introduction and aims; AUP has been purified from 11 week gestation 
decidual tissue using a three-step method of antibody affinity chromato­
graphy, ion exchange chromatography and gel filtration (Sutcliffe et al,
1980). Although this purification procedure was successful, the 
difficulty of obtaining decidua from early gestation precludes using 
this tissue for extraction of AUP on a larger scale. In contrast, 
samples of amniotic fluid are readily available at term, and during the 
second trimester of gestation from amniocenteses. The purification of 
AUP from amniotic fluid was therefore attempted. If this was 
successful, it would enable the following studies to be undertaken in 
the future:
1) a more detailed comparison of the structure and properties of AUP 
from uterine decidua and amniotic fluid.
2) the establishment of a radioimmunoassay experiment to detect trace 
amounts of AUP in maternal and fetal tissues thereby elucidating 
the complete tissue distribution of this protein,
3) the production of a higher titre antiserum to AUP for use in future 
experiments, eg, the localisation of AUP in maternal or fetal tissues 
by immunofluorescence.
Two different methods were used in an attempt to purify AUP 
from amniotic fluid. The first method adopted was similar to that 
used previously by Sutcliffe ^  ^  (1980), ie, a three-step regime of 
antibody affinity chromatography, ion exchange chromatography and gel 
filtration. A shorter two-step method, consisting of ion exchange 
chromatography followed by Con-A Sepharose chromatography was also tried.
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a) Purification of AUP by antibody affinity chromatography, ion 
exchange chromatography and gel filtration
Methods ; The source of AUP used in this purification procedure was
pooled amniotic fluid samples of various gestations, collected by 
amniocentesis. The total protein concentration of this material was 
4,9 mg/ml.
Antibody affinity chromatography; This step was performed on a column 
of Sepharose (Pharmacia) to which was coupled rabbit immunoglobulin 
raised against AUP from human amniotic fluid. The production of the 
anti-AUP serum and the preparation of the affinity column are described 
elsewhere (Sutcliffe et al, 1978, 1980), The bed volume of the column 
was approximately 90 ml, A total of nine samples of amniotic fluid 
were applied to the column. The binding capacity of the column was 
estimated by increasing the volume of the samples applied until AUP 
was detectable in the run through material. Each sample was applied 
to the affinity column then washed through with phosphate buffered 
saline (PBS) at 20 ml/hr at 4°C, Run through fractions were collected 
and monitored spectrophotometrically at 280 nm to determine total 
protein concentration. When the absorbance at OD280 reached background 
levels the remaining protein bound to the column was eluted with 50 ml 
of 2M potassium iodide, 50 mM Tris, pH 8,0 at 100 ml/hr at 4°C.
Fractions were collected as before and monitored for total protein.
The column was then rapidly washed with PBS (200 ml/hr) to remove 
residual KI. After about 40 minutes the flow rate was reduced to 
20 ml/hr and the PBS wash was continued overnight before the next 
sample of amniotic fluid was applied. Run through and eluate fractions 
were assayed for AUP by one-dimensional AACE using anti-AUP serum,
Eluate fractions found to contain AUP were pooled into a total volume
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of 921 ml then dialysed against two changes, each of 5 litres, of 
10 mM potassium phosphate, 50 mM NaCl, pH 7,5 for 24 hours, followed 
by three changes, each of 5 litres, of 10 mM potassium phosphate, pH 
7,5 for 36 hours. The dialysed material was then concentrated 
approximately five-fold by ultrafiltration using an Amicon PM-10 
membrane (exclusion limit ; 10,000 daltons) to yield a final volume 
of 191 ml.
Ion exchange chromatography; This step was carried out on a column of 
DEAE-Sepharose GI-6B (Pharmacia) of approximately 220 ml bed volume. 
After equilibration with 10 mM potassium phosphate, pH 7,5 at 4°C,
150 ml of the concentrated eluate from the affinity column was applied 
to the ion exchange column. This was washed through with 10 mM 
potassium phosphate, pH 7,5 at 40 ml/hr at 4^G until the absorbance at 
OD280 reached background levels, A linear gradient, starting with 
500 ml of 10 mM PO^, 0,IM NaCl, pH 6,5 and ending with 500 ml of 10 mM 
PO^, 0.5M NaCl, pH 6,5 at 40 ml/hr at 4*^ C was then applied to the 
column. Both run through and eluate fractions were once again assayed 
for AUP by one-dimensional AACE, In addition, conductivity of the 
material eluted from the column by the ion exchange gradient was 
measured using a conductivity meter (Radiometer, Copenhagen) in order to 
determine the mean salt concentration at which AUP dissociates from 
the column. In order to further purify AUP, the ion exchange step was 
repeated using a longer gradient. After re-equilibration of the column 
with 10 mM potassium phosphate, pH 7,5, the peak AUP fractions from the 
first ion exchange step were pooled into a volume of 49 ml, diluted 
five-fold to reduce the salt concentration, then applied to the column 
as before. This material was washed through with 10 mM PO^, pH 7,5
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and run through fractions collected until the OD280 fell to background 
levels. The second linear gradient was then applied to the column, 
starting with one litre of 10 mM PO^, 0.05M NaCl, pH 6,5 and ending 
with one litre of 10 mM PO^, 0.2M NaCl, pH 6,5, at 40 ml/hr at 4^G,
Both run through and eluate fractions were assayed for AUP by ID AAGE, 
In addition, the eluted material was assayed for albumin by ID AAGE 
using anti-human albumin serum (Behningwerke),
Gel filtration; The peak AUP fractions eluted from the second ion
exchange run were pooled and concentrated by ultrafiltration to a 
volume of 12.5 ml. This material was further concentrated to a final 
volume of 6 ml by lyophilisation, weighted with glycerol then applied 
to a 3,5 X 90 cm column of Sephadex G-150 (Pharmacia). The column 
was washed with PBS at 10 ml/hr at 4°G and fractions collected and
assayed for AUP and albumin by ID AAGE as before.
Results and Discussion
Affinity chromatography; Volumes of amniotic fluid ranging from 
15-100 ml were applied to the antibody affinity column. When samples 
of 50 ml and 100 ml were applied, AUP was detectable in run through 
fractions in concentrations measurable by AAGE. No AUP was detectable
in the run through when the sample volume was 15 ml, whereas AUP was
just detectable in the run through by AAGE when 20 ml amniotic fluid 
was applied to the column. During the course of the purification, 
the amniotic fluid pool used as the starting material was also used as 
a reference standard in quantitations of AUP by AAGE, and as such was 
arbitrarily said to have an AUP concentration of 1 unit/ml. Thus, the 
column capacity was approximately 20 ’’units'* of AUP, The AUP 
recovery data from the nine separate runs of the column is summarised
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in Table 6, The overall recovery of AUP from the antibody affinity 
chromatography step was 39%. An identical recovery from this step was 
reported by Sutcliffe ^  ^  (1980) during the purification of AUP from 
uterine decidua.
Ion exchange chromatography; A volume of 150 ml of the pooled material 
eluted from the affinity column was applied to the column of DEAE- 
Sepharose G1-6B, This material contained approximately 57 mg protein 
and 0,52 units AUP/ml, therefore a total of 78 "units" of AUP were 
applied. The protein profile of the material eluted with the first 
gradient of 0.1-0.5M NaCl is shown in Fig 20. No AUP was detectable in 
the run through fractions by one-dimensional AAGE, but this protein was 
found in a total of 18 x 10 ml eluate fractions (nos, 7-24 on Fig 20) 
by this method. Fraction nos. 7, 8 and 9 contained maximal levels of 
AUP. On inspection of the protein profile, it was evident that AUP 
was eluted in three protein peaks, and that the third peak which 
contained the maximum AUP concentration merged with another major 
protein peak. From a standard curve of conductivity against molarity 
(Fig 21), it was estimated that AUP was eluted at salt concentrations 
ranging from 0.045-0.20M. The major contaminant is likely to be serum 
albumin, because this dissociates from DEAE-Sepharose at a mean salt 
concentration of 0.18M NaGl (Sutcliffe 1980). In order to
determine more accurately the mean salt concentration required to 
dissociate AUP from the column and to separate AUP from the major 
contaminant protein(s) visualised in Fig 20, the ion exchange step was 
repeated using a longer gradient of 0,05-0.2M NaGl, as described in the 
Materials and Methods section. Six fractions (nos, 14-19) from the 
first ion exchange step containing high levels of AUP were pooled into
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a volume of 49 ml. This pooled material, which contained 0,19 mg/ml 
total protein and 1.13 units AUP/ml (as estimated by ID AAGE), was 
applied to the column and run through and eluate fractions collected as 
before. However, when these fractions were monitored for absorbance 
at 0D280, only trace amounts of protein were found, AUP was not 
detectable in the run through fractions by ID AAGE but was detected in 
a total of 36 eluate fractions by this method. No albumin was 
detected in these 36 fractions by ID AAGE, Examination of the conduct­
ivity measurements of the eluate fractions revealed that the conduct­
ivity rose initially then reached a plateau, which suggests that the 
ion exchange gradient was insufficiently mixed during the course of 
the experiment. In Fig 22 the conductivity profiles of the material
eluted during the first and second runs of the ion exchange column are
compared. The eluate fractions from the second ion exchange run, 
containing maximal levels of AUP as determined by ID AAGE were pooled 
into a volume of 194 ml. This was concentrated by ultrafiltration to 
a final volume of 12,5 ml. The concentrated material contained 0.55 mg 
protein and 0.24 units AUP/ml, The recovery of AUP from the two ion 
exchange steps is summarised below:
Starting material: pooled material from affinity chromatography
step.
Volume : 150 ml
AUP concentration : 0,52 units/ml
Total AUP ; 78 units
r
1st ion exchange step
1st ion exchange eluate (pooled fractions 14-19)
Volume : 49 ml
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AUP concentration : 1,13 units/ml 
Total AUP : 55,37 units
Recovery of AUP after 1st ion exchange step was 
approximately 71%
2nd ion exchange step
i
2nd ion exchange eluate 
Volume : 12,5 ml
AUP concentration : 0,24 units/ml 
Total AUP Î 3 units
, . Recovery of AUP after 2nd ion exchange step was 5,4%
It is evident that there was a much reduced recovery of AUP 
from the second ion exchange step. Measurement of the conductivity 
of the material eluted by the second ion exchange gradient revealed 
that the maximum conductivity corresponded to a salt concentration of 
0,115M NaCl, and that the fractions containing AUP were eluted at salt 
concentrations ranging from 0,075-0,115M NaCl, It was previously 
reported that AUP dissociates from DEAE-Sepharose at a mean salt concen­
tration of 0,13M NaCl (Sutcliffe et al, 1980), Therefore, it is 
possible that the majority of the AUP applied to the column remained 
bound because the ionic strength of the eluting gradient was insufficient­
ly high to effect dissociation. However, application of another 
gradient of increased ionic strength, starting with 950 ml of 10 mM 
PO^, 0,05M NaGl, pH 6,5 and ending with 950 ml of 10 mM PO^, 0.3M NaGl, 
pH 6,5 failed to recover any AUP which may have been adsorbed on to 
the column. An alternative hypothesis which may account for the low 
recovery of AUP from the second ion exchange step is that dénaturation 
of AUP occurred during the extensive purification procedure.
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Gel filtration; The material containing AUP recovered from the second 
ion exchange step was further concentrated by lyophilisation to a 
final volume of 6 ml and applied to a column of Sephadex G-150, as 
described in the Materials and Methods section. This gel filtration 
step was carried out in an attempt to recover a small (pg) amount of 
AUP, However, no AUP was detectable in any of the one ml fractions 
collected. The possible reasons for this failure to recover any AUP 
from the gel filtration step are as follows:
1) The large dimensions of the column used (3,5 x 90 cm) may have 
resulted in extreme dilution of AUP, to the extent that the concentration 
in the fractions collected was below the limit of detection by AAGE,
2) Dénaturation of AUP may have occurred during gel filtration,
3) AUP may have adsorbed to the column of Sephadex G-150 under the 
experimental conditions employed. This is unlikely, however, because 
similar conditions of temperature, buffer etc were used in a previous 
gel filtration experiment, using the same column of Sephadex G-150, 
with successful results, (See section 1 of "Results"),
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Table 6. The recovery of AUP from antibody affinity chromatography 
during the three-step purification procedure
Material Volume
ml
(AUP) 
units/ml
AUP
units
(X)
Protein
mg
(Y)
AUP/protein 
units/mg 
(X/Y)
Applied to column 360 1 360 1764 0.20
Not retained by 
column 791.5 0.13 104.11 1458.2 0.07
,*• retained prior 
to elution - - 255,89 305.8 0.84
Eluted in 2M KI, 
50 mM Tris 191 0.52 99,84 72.85 1,37
% recovery 39%
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Fig. 20. Spectrophotometric trace of protein eluted from a
DEAE-Sepharose C1-6B column with an ion exchange 
gradient of 0.1-0.5M NaCl. Horizontal line 
indicates fractions containing AUP. Shaded area 
indicates fractions pooled.
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Fig. 22. Comparison of the conductivity profiles of the ion exchange 
eluates from the first and second gradients, in the three- 
step purification procedure. a) 1st ion exchange step. 
Gradient: 500 ml 10 mM PO., O.IM NaCl, pH 6.5 - 500 ml 
10 mM PO,, 0.5m NaCl, pH 6.5. b) 2nd ion exchange step.%  ' 
Gradient : 1 litre 10 mM PO , 0.05M NaCl, pH 6.5 - 1 litre
10 mM PO^, 0.2m NaCl, pH 6.5.
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b) Purification of AUP by ion exchange chromatography and GoncanavaIiii"A 
Sepharose chromatography
This two-step method of purification was adopted in an attempt 
to minimise the technical problems encountered during the first proced­
ure, In particular, an alternative step to gel filtration, which may 
cause dilution problems was sought. It is possible that AUP is a 
glycoprotein, although there is as yet no unequivocal evidence to 
support this theory. For this reason, the method of Con-A Sepharose 
adsorption was utilised.
Methods ;
Ion exchange chromatography; Pooled amniotic fluid of 16-22 weeks' 
gestation and protein concentration 5,2 mg/ml was filtered through 
Whatman No, 1 paper to remove particulate material then dialysed over­
night against 10 mM potassium phosphate, pH 7,5, This starting 
material was used as the reference standard in AUP quantitations through­
out the purification procedure, hence was arbitrarily said to have an 
AUP concentration of 1 unit AUP/ml, The column of DEAE-Sepharose 
C1-6B used in the preceding experiment was re-equilibrated with 10 mM 
PO^, pH 7,5, at 4^C. The ion exchange step was performed twice: in
the first run, 75 ml of amniotic fluid was applied and in the second run 
100 ml of amniotic fluid. The experimental conditions of temperature, 
buffers, flow rate etc, were constant during each run of the column.
Each amniotic fluid sample was applied to the column and washed through 
with 10 mM PO^, pH 7,5 at 40 ml/hr, 4°C, until the absorbance at OD280 
reached background levels, A linear gradient, starting with 750 ml of 
10 mM PO^, 0.05M NaGl, pH 6,5 and ending with 750 ml of 10 mM PO^, 0.3M 
NaCl, pH 6,5 at 40 ml/hr, 4*^ C was then applied. Finally, the column
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was washed with approximately one bed volume of the highest ionic 
strength buffer, 10 mM PO^, 0.3M NaCl, pH 6,5. The protein concen­
tration profile (absorbance at 0D280) and conductivity of the eluted 
material were monitored. Both run through and eluate fractions were 
assayed for the presence of AUP by ID AACE as before, Eluate fractions 
containing AUP from each run of the column were pooled into four 
separate batches according to AUP concentration and the extent of serum 
protein contamination. Each pool was then concentrated by ultra­
filtration using an Amicon PMIO membrane and assayed for total protein 
concentration using the Folin reaction, and AUP concentration by ID AACE,
Concanavalin-A Sepharose Chromatography: Two preliminary experiments
were carried out to determine the suitability of this technique for 
AUP purification. These were as follows :-
1) Dialysis of amniotic fluid against Page^buffer. This buffer 
contains magnesium and calcium ions which are essential components in 
the binding reaction between Concanavalin-A and glycoproteins. This 
experiment was carried out in order to determine whether exposure to 
Page^ buffer caused dénaturation of AUP, A 15 ml volume of amniotic 
fluid (pooled from various gestations), of protein concentration 5-6 
mg/ml was filtered through Whatman No. 1 paper to remove particulate 
material then dialysed overnight against 2 litres of Pagd^ buffer at 4°C, 
followed by 2 litres of 10 mM potassium phosphate, pH 7,5 at 4°C, An 
aliquot of amniotic fluid was removed after each stage of dialysis and 
assayed for AUP by ID AACE, Protein dénaturation results in an 
alteration of the normal peak morphology on AACE,
2) Con-A Sepharose chromatography of crude amniotic fluid. This 
experiment was performed to determine whether or not AUP binds to
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Concanavalin-A. A column of 1 x 15 cm (K9, Pharmacia) was used in 
this, and subsequent Con-A Sepharose adsorption experiments. The 
column comprised a basal layer of approximately 0,5 cm depth of 
Sephadex G-25 (Pharmacia) and an upper layer of 5 ml Con-A-Sepharose 
(Pharmacia), previously equilibrated with Page^ buffer. Ten ml of 
amniotic fluid, of protein concentration 5,33 mg/ml was dialysed 
against Page buffer then applied to this column. The sample was 
washed through with the same buffer at 32 ml/h and run through fractions 
collected. Unadsorbed protein was monitored by Uvicord (LKB), which 
measures absorbance at 0D254, and washing was continued until the 
protein in the run through declined to background levels. The column 
was then eluted with 50 mM raethyl-a-D-glucopyranoside at 32 ml/hr until 
a second protein peak was observed on the Uvicord trace. When no 
more protein was detectable in the eluate, the column was re-equilibrated 
with Page^ buffer. All fractions were assayed for AUP and serum proteins 
by ID AACE, Eluate fractions containing the maximum amount of AUP were 
pooled and assayed for protein and AUP concentration. In addition, 
the extent of serum protein contamination in this material was estimated 
by two-dimensional AACE, using antiserum raised in sheep against human 
serum proteins,
Con-A Sepharose chromatography of partially-purified AUP
After these preliminary experiments, the Con-A Sepharose 
chromatography step was repeated using partially-purified AUP obtained 
from the preceding ion exchange step. The experimental procedure used 
was identical to that described above, with two exceptions. Firstly, 
the flow rate was reduced to 28 ml/hr, and secondly, the eluting buffer 
used was FM methyl-a-D-glucopyranoside, Two separate adsorption
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experiments were carried out. In the initial experiment, the starting 
material was the peak AUP cut (pooled fractions 88-97) from the first 
ion exchange run. In a further experiment, three batches of ion 
exchange eluate fractions containing AUP; nos 68-87 and 98-105 from 
the 1st ion exchange run and nos, 71-93 from the 2nd ion exchange run 
were pooled and applied to the Con-A Sepharose column.
Results and Discussion
Ion exchange chromatography: No AUP was detectable in the run through
fractions by one-dimensional AACE, However, AUP was detected by this 
method in a total of 73 eluate fractions (nos, 68-105) from the first 
run of the column and in 69 eluate fractions (nos, 65-109) from the 
second ion exchange run. The volume of each fraction was approximately 
8 ml. Thus it was apparent that AUP did not elute from the column as 
a sharp peak of protein, but a gradual dissociation occurred as the 
ionic strength of the eluting buffer increased. Fig 23 shows the 
protein concentration and conductivity profiles of the material eluted 
by the ion exchange gradient during the first run of the column, A 
similar protein and conductivity profile was obtained from the second ion 
exchange run. From the conductivity measurements of the eluate 
fractions containing maximal levels of AUP (as measured by ID AACE) in 
each ion exchange run, it was estimated that AUP eluted at a mean salt 
concentration of 0.125M NaCl during the first run and at 0,14M NaCl 
during the second run. These results compare favourably with the 
value of 0,13M NaGl reported by Sutcliffe e^ ^  (1980), From inspection 
of the data on protein concentration changes and AUP concentration 
changes in the eluate fractions measured by ID AACE, fractions containing 
AUP from each ion exchange run were combined into three separate pools
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(as indicated by the shaded areas in Fig 23). Since the majority of 
protein present in amniotic fluid is of serum origin (see main "intro­
duction"), the total protein present reflects the degree of serum protein 
contamination in the eluate fractions. Thus, in each case, "pool 1" 
contained a relatively low concentration of both AUP and serum proteins, 
"pool 2" contained the maximal AUP concentration but a higher degree of 
serum protein contamination, and "pool 3" contained a relatively high 
AUP concentration but was extensively contaminated with serum proteins. 
Each pool was concentrated by ultrafiltration using an Amicon PM-10 
membrane then assayed for total protein and AUP concentrations. The 
results are shown in Table 7, The recovery of AUP from the ion exchange 
step could not be estimated because the amount of protein which remained 
bound to the column after the run through step was not measured.
However, the amniotic fluid applied to the column had an AUP concen­
tration of 1 unit/ml or 0,19 units/mg protein. Thus it was apparent
that there was a considerable enrichment of AUP after the ion exchange 
step, particularly in pooled fractions 88-97 from the first run which 
contained 8*6 units AUP/mg protein, ie, about 45 times the concentration 
of AUP in the starting material. The second ion exchange run was less 
successful in that there was a much lesser enrichment of AUP and more
serum protein contamination. This probably reflects the increased
loading of the column: 100 ml amniotic fluid containing 520 mg protein
was applied compared with 75 ml amniotic fluid containing 390 mg protein 
in the first ion exchange run.
On the basis of the results shown in Table 7, pooled fractions 
88-97 from the first ion exchange run were used as the starting material 
for the next stage of the purification procedure because, out of the six 
ion exchange pools, this pool contained the maximum concentration of AUP
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per mg protein, combined with the minimum total protein concentration, 
Con-A Sepharose chromatography;
1) Dialysis of amniotic fluid against Pag^buffer. No difference was 
observed in the morphology of the AUP precipitin peak on ID AACE after 
dialysis of amniotic fluid against Pag^ buffer. It was therefore 
concluded that exposure to Pag^ buffer does not cause dénaturation of AUP,
2) Con-A Sepharose chromatography of crude amniotic fluid. From the 
Uvicord protein trace (absorbance at OD254) of the fractions obtained 
from the column after application of 10 ml amniotic fluid it was 
apparent that there was a much greater amount of protein in the run 
through fractions (unbound protein) than in the eluate fractions (protein 
bound to the column and dissociated with methyl-a-D-glucopyranoside). In 
addition, protein eluted from the column as a sharp, discrete peak. 
Elution commenced at fraction no. 41, Low concentrations of AUP were 
detectable by ID AACE in a total of seven run through fractions (nos, 
16-22), which indicates that the column was overloaded. Higher concen­
trations of AUP were found in eluate fractions 47-57 by this method.
This suggests that AUP adsorbed to Con-A and was subsequently eluted 
with methyl-a-D-glucopyranoside, Serum proteins, predominantly 
albumin were present in all fractions assayed. However, the albumin 
concentration was lower on the eluate than in the run through fractions 
and declined as elution progressed. This suggests that albumin does 
not bind specifically to Con-A Sepharose, but is present in the eluate 
due to insufficient washing of the column to remove unadsorbed protein 
prior to the elution step, A total of six eluate fractions, containing 
maximal concentrations of AUP were pooled into a volume of 9 ml. The 
concentrations of protein and AUP in this pool were measured in order
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to estimate the degree of enrichment of AUP after Con-A Sepharose 
chromatography (see Table 8), From these results it was apparent that 
the concentration of AUP per mg protein was more than 3-fold greater in 
the eluted material than in the starting material. Recovery of AUP 
after this step could not be accurately determined due to overloading 
of the column.
The results of this preliminary study indicated that AUP 
bound to Con-A Sepharose and was eluted with methyl-a-D-glucopyranoside 
and that during this procedure a 3-fold enrichment of AUP occurred. It 
was therefore concluded that Con-A Sepharose chromatography was a 
suitable second step in the purification procedure.
Con-A Sepharose chromatography of partially-purified AUP,
In the initial experiment, 9 ml of pooled ion exchange 
fractions 88-97 (from the first ion exchange run) was applied to the 
column. This material contained 2,43 mg protein and approximately 21 
units of AUP. However, after Con-A Sepharose chromatography only trace 
amounts of AUP were detected by ID AAGE in the eluate. The most likely 
explanation for this poor recovery of AUP is that an insufficient 
quantity of protein was applied to the column, with the result that the 
concentration of AUP in the resultant fractions was lowered by dilution. 
Therefore, a second experiment was carried out, in which a greater 
amount of protein was loaded on the column. Fraction nos, 68-87 and 
98-105 from the first ion exchange run and nos, 71-93 from the second 
ion exchange run were combined into a single pool, of volume 33,3 ml.
Of this, 28 ml was applied to the Gon-A Sepharose column. The run 
through and elution stages were carried out as before and fractions 
collected. The protein profile of the resultant fractions is illustrated
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in Fig 24. Elution commenced at fraction no. 50, Trace amounts of 
AUP were detectable by ID AACE in run through fractions 25-35, whereas 
much greater concentrations of AUP were detected in eluate fractions
56-70 by this method. As the run through step progressed, the concen­
tration of albumin (as measured by ID AACE) diminished until a constant 
low level was reached. In addition, both the concentration and 
number of other serum components decreased (see Fig 25a),. On elution 
with glucopyranoside however, an increased number of serum contaminants 
was observed, indicating that several serum glycoproteins were present 
in the starting material applied to the column. However, minimal 
concentrations of albumin, the quantitatively major serum contaminant, 
were present in the eluted material (see Fig 25b), A total of seven 
eluate fractions (nos, 62-68) which contained relatively high concen­
trations of AUP but relatively low levels of serum proteins were pooled 
into a final volume of 8 ml. The recovery of AUP in these fractions
is shown in Table 9, Note that although AUP was detectable in several 
run through fractions, the concentration of AUP in this material was 
too low to be accurately measured by ID AACE, Thus, almost all the 
AUP applied to the column adsorbed to Con-A. Although the recovery of 
AUP was relatively low, ie, about one-fifth of the AUP applied to the 
column was recovered in fractions 62-68, AUP was detected in several 
other eluate fractions not included in this pool. Thus the overall 
recovery of AUP after Con-A Sepharose chromatography was somewhat 
higher than this value. This step also resulted in further enrich­
ment of AUP by about two-fold, as outlined below:
Summary of purification of AUP by two-step method.
Starting material : amniotic fluid
AUP concentration : 0,19 units AUP/mg protein
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i
Ion exchange chromatography
i
Pooled ion exchange fractions from 1st and 2nd runs of column
AUP concentration : 2,37 units AUP/mg protein
There was a 12,5-fold enrichment of AUP after ion exchange
i
Con-A Sepharose chromatography
i
Pooled eluate fractions (nos, 62-68)
AUP concentration : 4.03 units AUP/mg protein
. . There was a 1.7-fold enrichment of AUP after Con-A Sepharose 
chromatography.
Therefore after the two purification stages the concentration 
of AUP increased by approximately 21-fold. In order to estimate the 
degree of serum protein contamination in the pooled fractions (62-68) 
eluted from the Con-A Sepharose column this material was analysed by 
two-dimensional AACE using antiserum raised against adult human serum. 
The results were compared with those of a corresponding assay of the 
material applied to the Con-A Sepharose column. The 2D AACE was semi- 
quantitative in that the same amount of AUP (punits) was applied to 
each plate. The results are shown in Fig 26, The major serum protein 
detected was albumin. For a given protein, the area enclosed by the 
precipitin peak on AACE is proportional to its concentration. Thus, 
a rough estimate of the reduction in albumin concentration in the 
partially-purified material obtained after the Con-A Sepharose step 
was obtained by comparing the areas under the albumin peaks on each
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plate. The concentration of albumin in the starting material (pooled 
ion exchange fractions 68-87 -f 98-105 4- 71-93) was found to be 
approximately 12 times that in the material eluted from the Con-A 
Sepharose column.
Therefore, the two-step purification procedure devised was 
more successful for the purification of AUP from amniotic fluid than 
the three-step procedure used previously by Sutcliffe ^  al^  (1980). 
However, due to the relatively low amount of partially-purified AUP 
obtained from the two-step purification, no further purification was 
attempted.
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Fig. 23. Total protein and conductivity profiles of amniotic
fluid components eluted from DEAE-Sepharose C1-6B 
using a linear gradient of 750 ml 10 mM PO^, 0.05M 
NaCl, pH 6.5 to 750 ml 10 mM PO^, 0.3M NaCl, pH 6.5. 
The shaded areas represent fractions pooled.
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Table 7. Protein and AUP concentrations of the pooled ion exchange
material.
Pool Fractions 
pooled 
(nos.)
Volume
(ml)
Protein cone 
(mg/ml)
Protein
(mg)
AUP cone AUP AUP/pr&tein 
(units/ml) (units)(units/mg)
1 68-87 11,4 0.44 5.02 0.64 7.30 1.45
2 88-97 12.2 0.27 3.29 2.32 28.30 8.60
3 98-105 9.5 1.39 13.21 5.18 49.21 3.73
1 65-70 9.1 0.67 6.10 NT NT NT
2 71-93 12.4 0.62 7.69 0.40 4.96 0.64
3 94-109 22.8 5.68 129.50 0.49 11.17 0.09
I
I
NT = not tested
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Table 8 . Enrichment of AUP after Con-A Sepharose chromatography of 
crude amniotic fluid.
Volume Cone of AUP AUP Protein AUP/protein
(ml) (units/ml) (units) (mg) (units/mg)
Material applied 
to column 10 1.86 18.6 53,30 0.35
Material eluted 
from column 9 0.59 5.31 4.41 1.20
Table 9, Recovery of AUP after Con-A Sepharose chromatography of
pooled ion exchange eluate fractions.
Material Vol
(ml)
AUP
(units/ml)
AUP Protein 
(units) (mg)
X Y
AUP/protein
(units/mg)
X/Y
Applied to column 28 1,85 51.80 21.84 2.37
Not retained by 
column 39.5 15.28 -
.* * Retained before 
elution - - 51.80 6.56 7.90
Eluted in fractions 
62-68 8 1.33 10.64 2.64 4.03
% recovery 20.5
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Fig. 25,
a) One-dimensional AACE illustrating the serum protein contaminants 
present in run through fractions from Gon-A Sepharose chromatography 
of partially-purified AUP. Antiserum: 4% S^^^, a sheep antiserum
to adult human serum. Antigens (L - R): Amniotic fluid (control)
(5 pi), fraction nos. 30-43 from Con-A Sepharose column (10 pi of 
each fraction).
b) One-dimensional AACE of the serum protein contaminants in fractions 
eluted from the Con-A Sepharose column. Antiserum; 4%
Antigens (L - R): Amniotic fluid (control) (5 pi), fraction nos.
57-65 (10 pi of each fraction).
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Fig. 26. Semi-quantitative assay by two-dimensional AACE of the 
residual serum albumin present after Con-A Sepharose chromatography of 
AUP partially-purified by ion exchange chromatography. Antiserum 
(both plates) ; 4% S^Sg.
Antigens: Upper plate. Pooled ion exchange fractions 68-87 + 98-105 +
71-93 (4.3 III).
Lower plate. Pooled fractions 62-68 from Con-A Sepharose 
column (6 |il).
Both antigens contained approximately 8 |j. units of AUP. The single 
circle at the RHS of each plate denotes albumin mobility in the first 
dimension.
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7. Radioiodinatlon and analysis of partially-purified AUP
Introduction; In the preceding section partial purification of AUP 
from human amniotic fluid was reported. In order to determine the
nature and degree of purity of this material, an aliquot was radio-
125 125
labelled with Iodine and the I-labelled AUP analysed by SDS-poly-
acrylamide gel electrophoresis after extraction from a precipitin arc
on AACE.
Methods ; A total of four 10 pi aliquots of partially-purified AUP 
(fractions 62-68 eluted from the Con-A Sepharose column) were radio- 
iodinated by the chloramine-T method of Hunter and Greenwood (1962).
After the iodination reactions, labelled protein was separated from 
free radioiodide by passage through a small column of Sephadex G-25 
(Pharmacia).
One-dimensional AACE: In a preliminary experiment, 5 pi volumes of
the radiolabelled material were combined with 5 pi of unlabelled 
amniotic fluid as a source of carrier AUP, and reacted against each of 
anti-AUP serum (raised in rabbit against decidual AUP) and sheep anti­
serum to adult human serum. To control for antiserum specificity, 2 pi 
of adult human serum was added to each alternate well on the AACE plates, 
A second AACE experiment was carried out in a similar manner. This 
time, 5 pi volumes of cold amniotic fluid carrier were combined with 
varying amounts of the tracer from 5-20 pi. AUP was assayed using two 
different antisera, raised against decidual and amniotic fluid AUP, 
respectively. As an additional control for nonspecific binding of the 
tracer, another AACE plate was run using serum from a non-immunised 
rabbit instead of a specific antiserum. All the AACE plates were dried
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and the resultant precipitin arcs detected by autoradiography using 
Kodak NS-2T film.
SDS-polyacrylamide gel electrophoresis; After autoradiography, the 
AACE plates were stained with 2% Goomassie blue and the AUP precipitin 
arcs cut out using a scalpel. These were placed in protease-free vials 
(3-4 arcs per vial) and incubated in (3-mercap to ethanol at lOO^C for 2 
hours to extract the protein then applied to a 4,5-12.5% SDS-poly- 
acrylamide slab gel. Carbonic anhydrase (MW 29,182) and pyruvate 
dehydrogenase were run alongside as molecular weight standards. The 
pyruvate dehydrogenase (PDH) was extracted from E. coli, and consists 
of three chains of MW 100,000, 80,000 and 56,000, respectively (Coggins 
^  a^, 1976), The slab gel was dried and stained with 0.2% Goomassie 
blue then subjected to autoradiography as before. Protein mobilities 
were estimated relative to the distance between the top of the running 
gel and the marker dye front (Bromophenol blue, BDH indicators), which 
was said to have an Rf value of 1. (see main "Materials and Methods" 
section for further details of SDS-polyacrylamide gel electrophoresis).
Results ; After radioiodinatlon the specific activities of the four 
aliquots of partially-purified AUP were 83, 79.25, 43.3 and 21 |xCi/ml, 
respectively. In the preliminary AACE experiment the tracer of 
highest specific activity was used. The autoradiograph of the two 
AACE plates (AUP and serum protein assays) is shown in Fig 27. In the 
AUP assay most of the radioactivity was concentrated inside the precipitin 
arc rather than on the periphery. In the serum protein assay radio­
activity was concentrated at the tip of the major precipitin arc 
which probably represents serum albumin. The addition of adult serum 
caused this major precipitin arc to "rocket". In the second AACE
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experiment radiolabelled aliquots of specific activities 79,25 and
43,3 pGi/ml were used. Four AACE plates were run, namely two AUP
assays, a serum protein assay and a control for non-specific binding of
the tracer. The resultant precipitin arcs were again examined by
autoradiography. The number of serum proteins present in the tracer
were indistinct on the autoradiograph but about 8 components were
visible after staining of the AACE plate. Again, addition of adult
serum to the tracer resulted in "rocketing" of the major precipitin
peak. Background radiation was detected on the specificity control
plate indicating that there was some non-specific binding of the tracer
to the gel. In the two AUP assays performed using antisera raised
against decidual and amniotic fluid AUP, respectively, the addition of
increasing volumes of tracer to a constant volume of cold carrier AUP
resulted in a progressive increase in the height of the resultant
precipitin arcs. This is additional evidence of the specificity of 
125
I-AUP. In both the AUP assays, radioactivity was again concentrated
within the precipitin peaks, (see Fig 28).
SDS-polyacrylamide gel electrophoresis; A total of 5 samples of 
125
precipitated I-AUP extracted from AACE were applied to a slab gel
as described in the Materials and Methods section. On staining the
gel, however, no bands other than those of the molecular weight
standards were visible. However, three bands were detected by auto-
125radiography of the gel in each of the 5 samples of I-AUP analysed
(see Fig 29), The molecular weights of these three bands were
estimated by comparing their mobilities with those of the molecular
weight markers as shown in Fig 30. The three components present in 
125
the I-AUP were found to have molecular weights of 48,000, 16,000 and
9,000 daltons, respectively.
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Discussion; The above results indicate that AUP was successfully 
radioiodinated and that the antigenicity of this protein was unaltered 
by the radioisotope, ie. no apparent dénaturation of AUP occurred.
In the AACE autoradiographs, the discovery of a concentration of radio­
activity within the AUP precipitin peaks may correlate with the previous 
observation that AUP reacted against antiserum to decidual AUP resulted 
in the production of "filled-in" peaks on AACE (see section 2 of "Results"), 
A more likely hypothesis is that this reflects non-specific binding of 
the tracer to the gel, since there is evidence that this occurred. In 
addition, in the second AACE experiment the counts were concentrated 
inside the AUP peaks when the antiserum used was raised against either 
decidual or amniotic fluid AUP,
It was also apparent from the AACE experiments that the 
partially-purified AUP contains several serum protein contaminants.
An attempt was made to isolate AUP from these contaminants by extracting 
125
I-AUP from AUP precipitin arcs on AACE. This material contained 
three components; a major band of MW 48,000 and two minor bands of
16,000 and 9,000 molecular weight, respectively. It is possible 
that the major band represents non-denatured AUP in view of the similarity 
between the MW of 48,000 and that estimated for AUP by gel filtration on 
Sephadex G-150, In a previous report evidence was presented that AUP 
is a dimer composed of two similar or identical subunits of approximately 
25000 molecular weight (Sutcliffe ^  ah, 1980). However, from the 
results of this study it appears possible that these subunits may undergo 
further degradation, to yield two peptide chains of 16000 and 9000 
molecular weight respectively. Thus, AUP may be a tetramer composed of 
two peptide chains of MW 16000 and two peptide chains of MW 9000. 
Alternatively, the two minor bands visualised on the SDS-polyacrylamide
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gel may represent low MW serum proteins or subunits of serum proteins 
which were present as contaminants in the partially-purified AUP,
It is unlikely that serum proteins would have been immune precipitated on 
AACE using anti-AUP serum because the antiserum was adsorbed of serum 
specificities. However, due to the fact that some non-specific 
binding of the tracer to the agarose gel on AACE was observed, it is 
possible that some serum proteins were extracted from the gel along with 
the precipitated AUP.
Clearly, further physicochemical studies using pure AUP are 
required to resolve the question of the subunit structure of this 
protein.
I
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125Fig. 27. Upper; Autoradiograph of one-dimensional AACE of I-
125
labelled AUP. Each well contained 5 pi I-AUP (partially-purified)
and 5 pi amniotic fluid (cold carrier AUP). Wells 2 and 4 (numbering 
from L - R) also contained 2 pi of adult human serum as a specificity 
control. The antiserum was raised in rabbit against decidual AUP and 
used at a final concentration of 207..
Lower; Autoradiograph of one-dimensional AACE of the serum proteins 
125
present in I-labelled partially-purified AUP. Contents of the 
wells are as described above. The antiserum was 47. sheep antiserum 
raised against adult human serum.
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é
125Fig. 28. Autoradiograph of one-dimensional AACE of I-labelled
AUP. The four wells in each case contain 5 pi cold carrier AUP
12 5
combined with (from L - R) 5,10,12 and 15 pi I-AUP (partially-
purified). The antisera were as follows;
Upper plate; Antiserum raised in rabbit against decidual AUP, used 
at a final concentration of 20%.
Lower plate; Rabbit antiserum to amniotic fluid AUP, used at a 
final concentration of 20%. Both antisera were adsorbed with adult 
human serum.
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125Fig, 29, Autoradiograph of the five separate samples of I-AUP
extracted from AUP precipitin arcs and analysed by SDS-polyacrylamide
gel electrophoresis under denaturing conditions. The small lines
at the RHS of the photograph indicate the positions of the MW standards.
These are (from top to bottom); 100,000 MW component of PDH, 80,000 MW
component of PDH, 56,000 MW component of PDH and carbonic anhydrase.
125The three bands visible on the autoradiograph correspond to I- 
labelled components of molecular weights (from top to bottom) 48,000,
16,000 and 9,000.
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Fig. 30. Estimation of the molecular weight of the subunits of 
125
I-labelled AUP by SDS-polyacrylamide gel electro­
phoresis. The mobility of the AUP components were 
compared to the standard curve shown above. Carbonic 
anhydrase and PDH were used as molecular weight standards 
to construct the curve.
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8 . Measurement of human serum and non-serum proteins in second
trimester amniotic fluid
Introduction; Alpha uterine protein is present in amniotic fluid and 
the concentration changes of this protein from 10 weeks of gestation to 
term have been measured (Sutcliffe nt al, 1978), However the origin of 
AUP in amniotic fluid is not known. The similarity between the concen­
tration profile of AUP in amniotic fluid during the second and third 
trimesters with that of two other non-serum proteins, al,4-glucosidase 
and prolactin, suggests that these three proteins may have a common 
origin during this period. The consistent presence of AUP in both 
pregnant and nonpregnant uterine tissue indicates that the uterus may 
be the major site of synthesis of this protein, hence the tissue of 
origin of amniotic fluid AUP, In addition, there is evidence that 
amniotic fluid prolactin originates from uterine decidua and possibly 
chorion (Riddick and Kusmik, 1977; Colander et al, 1978), The origin 
of al,4-glucosidase in amniotic fluid is uncertain, although a maternal or 
fetal nonserum source appears to be likely.
In contrast to the above-mentioned proteins, the quantitatively 
major proteins in amniotic fluid, which are of serum origin, attain 
maximal concentrations between 20 and 30 weeks of gestation (Sutcliffe 
and Brock, 1973), Evidence from genetic and quantitative studies 
indicates that these proteins in amniotic fluid have a maternal rather 
than fetal origin (Abbas and Tovey, 1960; Strebel, 1960; Derrington and
II II
Soothill, 1961; Ruoslahti e_t al, 1966; Seppala e_t al, 1966; Usategui- 
Gomez and Morgan, 1966; Gitlin and Biasucci, 1969; Sutcliffe ejt al,
1972; Johnson et al, 1974; Sutcliffe, 1975), However there is some
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conflicting evidence for albumin (Brzezinski e_t al, 1964) and a^-anti- 
trypsin (Kaiser et al, 1974).
In this study, the quantitative relationships between AUP, 
prolactin and al,4-glucosidase in amniotic fluid are investigated by 
measuring the concentrations of these proteins in amniotic fluid between 
16 and 19 weeks of gestation. Clearly, any correlation between these 
three proteins could argue in support of a common origin in amniotic 
fluid. The concentrations of some serum proteins in amniotic fluid 
were also measured in order to further examine the origins of albumin 
and a^^-anti trypsin.
Methods ; Twenty human amniotic fluid samples ranging from 16 to 19 
weeks of gestation were obtained by amniocentesis. All pregnancies 
proceeded normally and resulted in the delivery of normal infants.
After centrifugation at 10,000 g for 15 mins, the fluids were stored 
at -20^C prior to use. The concentrations of the seven proteins were 
assayed using the following methods. Alpha uterine protein, a^-anti- 
trypsin, group-specific component and albumin were assayed by one­
dimensional antibody-antigen crossed electrophoresis on 1% agarose gel 
as described by Brock and Sutcliffe (1972), The concentration of AUP 
was expressed arbitrarily as "units per ml sample", relative to a 
reference amniotic fluid sample. The concentration of a^-antitrypsin, 
Gc and albumin were calculated relative to reference standards of known 
concentration. The sources of these standards were "Protein-Standard- 
Serum Lc-V" and "Standard-Human-Serum, stabilized", both produced by 
Behringwerke AG, West Germany, AUP was assayed using an antiserum 
described previously (Sutcliffe et al, 1979), Commercial antisera 
(Behringwerke), raised in rabbit were used to assay a^-antitrypsin, 
Gc-globulin and albumin. These antisera were used at a final concen-
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tratlon of 1 % , Alpha 1,4-glucosidase was assayed by the method of 
Sutcliffe e_t ^  (1972). Alpha fetoprotein was assayed by the method 
of Allan e_t ^  (1973). The concentration of prolactin was measured by 
radioimmunoassay. The prolactin assay was kindly carried out by Dr.
A,M, Wallace, Senior Biochemist, Dept, of Biochemistry, Royal Infirmary, 
Glasgow, A statistical analysis of the results of the protein assays 
was carried out by computer, using the "Minitab" programme (Ryan _et al,
1976),
Results ; The concentrations of the various proteins were measured in 
20 independent samples of cell-free amniotic fluid and the mean concen­
trations and their ranges are shown in Table 10. The prolactin values 
recorded represent the mean of three assays performed at sample dilutions 
of 1:100, 1:500 and 1:1000, Due to a non-linear response at different 
dilutions in the majority of the samples the prolactin results were not 
included in the statistical analysis. Table 11 summarises the corre­
lation coefficients for each pair of proteins. Because of the multiple 
correlations to be carried out it was not necessarily admissible to 
accept a correlation as significant at p ^  0.05 since, on random 
sampling one might expect 5% of correlations to be positive. The
correlation matrix was therefore divided into two, placing the serum
proteins (Gc, AFP, albumin and anti trypsin) into one matrix and the
nonserum proteins into another. The modified values of r and p for
hypothesis testing are shown in Table 11. Three positive correlations 
were found, between albumin and anti trypsin (r = 0,594), albumin and 
Gc (r = 0,647) and between Gc and «^-antitrypsin (r = 0,814), No 
correlation was found between AUP and al,4-glucosidase (r = 0,024).
These results are shown graphically in Fig 31 a) - d).
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Discussion; The concentrations of «^-antitrypsin, albumin, «1,4- 
glucosidase, AUP and AFP are similar to levels previously reported at 
this stage of gestation (Sutcliffe et al, 1972b, 1978; Sutcliffe and 
Brock, 1973; Weiss at al, 1978), In the amniotic fluids assayed, the 
Gc concentration ranged from 12-34 mg/L, with a mean value of 24,2 mg/L, 
There have been no other studies on Gc levels in amniotic fluid at this 
stage of gestation. However, Brock and Nelson (1974) reported a mean 
Gc concentration of 32 mg/L in amniotic fluid between 29-42 weeks of 
gestation. Taking into account the pattern of concentration changes 
of Gc throughout gestation, these two mean values appear to be compatible. 
From the table of correlation coefficients, it is clear that 
there is no quantitative relationship between «1,4-glucosidase and AUP 
in the amniotic fluid samples examined. Thus the origin of the «1,4- 
glucosidase in the amniotic fluid remains undecided. In the prolactin 
assay a non-linear response was observed at different dilutions. To 
my knowledge there have been no reports of a similar response in assays 
of human pituitary prolactin. This may suggest that the molecular 
form of amniotic fluid prolactin differs from that of human pituitary 
prolactin. This appears unlikely since there is evidence that 
amniotic fluid prolactin is identical to human serum and pituitary 
prolactin as regards molecular size, net charge, biological activity 
and immunoactivity (Ben-David ^  al, 1973; Ben-David and Ghrambach,
1977), However, it has been reported that storage of prolactin for 
several months at -20^G results in a reduction in size of the hormone 
from a molecular weight of 30,000 to approximately 20,000 daltons 
(Rogol and Ghrambach, 1975), This may reflect either proteolysis or 
re-folding of the molecule in the frozen state. Since the amniotic 
fluid samples used in this study were previously stored at -20°G the
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results observed may reflect such an alteration of the prolactin 
molecule.
In contrast to the lack of correlation between the non-serum 
proteins in amniotic fluid, positive correlations are evident between 
the three serum proteins: albumin, Gc and «^-antitrypsin (Table 11,
Fig 31 a)-c)). Since the Gc in amniotic fluid is known to be mainly 
of maternal serum origin (see main "Introduction"), these correlations 
provide further evidence that the albumin and «^-antitrypsin in second 
trimester amniotic fluid are also mainly of maternal serum origin.
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Table 11. Correlation Coefficients (r) for serum and non-serum 
proteins in amniotic fluid.
Albumin Gc «^-antitrypsin
Gc 0,647*
«^-antitrypsin 0,594* 0,814* 6 comparisons
AFP -0,565 -0.054 -0,195
... AUP.
«-1,4-glucosidase 0,024 1 comparison
^Significant correlation. The critical value, p^, the probability of 
rejecting the null hypothesis in any one of n comparisons, was calculated 
as p/n, where n = number of comparisons in the matrix and p was set at 
0,05.
for n = 6,p^ = 5/6 = 0.83%, r =? 0,58 for 18 df 
for n = 1, p^ = 5/1 = 5,0%, r = 0.44 for 18 df
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Fig. 31. a) - c). Graphs of the positive correlations between 
levels of serum proteins in 20 separate samples 
of 2nd trimester amniotic fluid.
d)
a) Gc and albumin
b) oc^-anti trypsin and albumin
c) a^-antitrypsin and Gc
Graph illustrating the lack of correlation between 
levels of AUP and al,4-glucosidase in 20 separate 
samples of 2nd trimester amniotic fluid.
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9. An immunological comparison of Alpha uterine protein and 
Progestagen-dependent endometrial protein
Introduction; Progestagen-dependent endometrial protein (Joshi e^ al,
1980a,b) and alpha uterine protein are similar as regards glycoprotein 
nature, molecular size and subunit structure. In addition, both 
proteins are believed to be uterine-specific. Therefore, it is 
possible that AUP and PEP are the same protein. To investigate this 
hypothesis, anti-AUP serum and anti-PEP serum were tested for possible 
immunological cross-reactivity on a double immunodiffusion system.
Methods : Ouchterlony double immunodiffusion was carried out as
described in the main "Materials and Methods" section. Anti-AUP serum
was raised in rabbit against partially-purified AUP from 11 week gestation 
decidua (Sutcliffe ^  1980) and adsorbed with adult human serum.
Rabbit anti-PEP serum was raised against partially-purified PEP and 
adsorbed with adult human serum, A glycoprotein fraction of decidua 
was used as a source of PEP, The latter two reagents were kindly 
provided by Prof. S,G, Joshi, Dept, of Obstetrics and Gynecology, the 
Neil Heilman Medical Research Building, Albany Medical College, Albany,
New York 12208, U.S.A.
Results ; A reaction of complete identity was observed between anti-AUP 
and anti-PEP on double immunodiffusion. This is illustrated in Fig 
32 and 33, This result was confirmed in the New York laboratory.
Discussion; The results of this experiment indicate that AUP and PEP 
are the same protein. From studies carried out on this protein to 
date (Sutcliffe e_t 1978, 1979,1980; Joshi et al, 1980a,b) a con­
siderable amount of information is available, particularly regarding
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its physicochemical properties. However, as previously discussed (see 
section 4 of "Results") the complete distribution of this protein is not 
yet known. Alpha uterine protein has been detected by one-dimensional 
AACE in human endometrium, myometrium, decidua, amnion, chorion, amniotic 
fluid, early gestation (8-13 weeks) and term placentae, and fetal gut 
(Sutcliffe e_t al 1978, 1979 +  unpublished observations). In contrast, 
the presence of PEP has only been reported in human endometrium and 
decidua; it could not be detected in the other tissue examined so far, 
namely term placenta (Joshi et al, 1980a), This discrepancy may 
reflect the fact that Joshi and colleagues used the techniques of double 
immunodiffusion and immunoelectrophoresis which are less sensitive 
than AACE to detect PEP,
134
Fig. 32. Ouchterlony double immunodiffusion experiment illustrating 
immunological identity of alpha uterine protein (AUP) and progestagen- 
dependent endometrial protein (PEP). The following antigens and 
antisera were introduced into 4 mm diameter wells cut in 1% agarose. 
(Starting at the top and reading clockwise):
Well 1 : anti-PEP serum ( 10 |J.1).
Well 2 : pooled human amniotic fluid (54.8 ng protein; 10 mU AUP).
Well 3 : anti-AUP serum (20 M-1).
Well 4 : decidual glycoprotein fraction (source of PEP). (10 |il).
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Fig. 33. Ouchterlony double immunodiffusion experiment illustrating 
serological identity of anti-AUP serum and anti-PEP serum. Volumes 
(10 |il) of the following antigens and antisera were introduced into 4 mm
diameter wells cut in 17. agarose.
Wells 1 and 5 : pooled human amniotic fluid (54.8 |ig protein; 10 mU AUP),
Wells 2 and 4 : decidual glycoprotein fraction (source of PEP),
Well 3 : anti-PEP serum (5 |j.l) plus anti-AUP serum (5 |il).
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10. Progesterone-binding studies
Introduction; The physiological function of alpha uterine protein is 
not yet known. However, the presence of this protein in the uterine 
decidua, placenta, fetal membranes and amniotic fluid suggests that it 
has a pregnancy-associated function. One possibility is that AUP binds 
the steroid hormone progesterone. Progesterone is produced throughout 
gestation by the placenta, metabolised in fetal tissues then returned to 
the placenta for further conversion. Therefore progesterone receptor(s) 
may be involved in the transportation of this steroid hormone, A 
progesterone-receptor protein of 54000 molecular weight has been reported
t!
in the cytosol of human endometrium and myometrium (Janne e_t al^ , 1975).
The isoelectric point of this receptor was 4.8 with a second minor peak
focusing at pH 5.2. A similar isoelectric point of about 4.9 was
reported for progestagen-dependent endometrial protein (Joshi et al,
1980b), Therefore it is possible that AUP/PEP may represent the
11
uterine progesterone-receptor described by Janne e^ ^  (1975),
3
Methods ; (1,2- H)Progesterone of specific activity 40-60 Ci/mmole was
obtained from The Radiochemical Centre, Amersham. The source of AUP 
was material partially-purified from amniotic fluid by ion exchange 
chromatography (the first stage of the two-step purification procedure 
described in "Results" section 6). This partially-purified material 
contained 0,6 mg/ml protein and was enriched with AUP, having a concen­
tration of approximately 3 units AUP/mg protein compared with approx­
imately 0.2 units AUP/mg protein in the original amniotic fluid, ie. the 
AUP concentration was increased 15-fold after ion exchange chromatography. 
Progesterone-binding was measured by equilibrium dialysis using a 
method adapted from those described by Fridlansky and Milgrom (1976)
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and Follow £t ^  (1978), A preliminary experiment was carried out in 
order to find the time required to reach equilibrium. The AUP
t»
solution (1 ml) was dialysed (2-8 x 32 dialysis tubing, Medicell Inter-
3
national Ltd.) against 15 ml of 20 nmolar (1,2- H)Progesterone solution 
containing a 100-molar excess of cortisol at 4°C, with shaking. All 
the steroid solutions used in the equilibrium dialyses were prepared 
using 73 nM sodium phosphate buffer, pH 7.4. Cortisol was added to 
eliminate binding of progesterone by contaminating corticosteroid- 
binding globulin (transcortin) which specifically binds cortisol, 
corticosterone, progesterone and 17o:-hydroxyprogesterone. At various 
times from 0-38 hours, a 100 pi aliquot was removed from the solution 
outside the dialysis bag and the level of radioactivity present 
counted. In the subsequent equilibrium dialysis experiment 1 ml 
volumes of partially-purified AUP were dialysed as described above
3
against increasing concentrations of (1,2- H)Progesterone (0.2, 0.5, 1, 
2, 5, 10, 15 and 20 nmolar) in 15 ml of 73 nM sodium phosphate buffer, 
pH 7.4 at 4°C for the time required to reach equilibrium. As in the 
preliminary experiment, a constant amount of unlabelled cortisol,
3
100-fold molar excess over the highest ( H) steroid concentration was 
added to each steroid solution. As a positive control, an identical 
equilibrium dialysis experiment was performed using maternal serum of 
protein concentration 0.6 mg/ml in place of the partially-purified AUP, 
Maternal serum contains elevated levels of corticosteroid-binding 
globulin (Klopper and Fuchs, 1977). Therefore in this experiment, 
cortisol was omitted from the steroid solutions. After dialysis, the 
vials (16 in total) were removed from the cold room on ice and the 
contents of the dialysis bags emptied into separate vials. The 
solutions were allowed to reach room temperature then 100 pi volumes
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from each (ie. from inside and outside each dialysis bag) were intro­
duced into separate scintillation vials containing 10 ml Biofluor (New 
England Nuclear), and counted for 2 minutes in a Liquid Scintillation 
Spectrometer (Intertechnique, Model SL-30), Each scintillation vial 
had been precounted before the addition of steroid solution in order to 
establish the background counts. The results were analysed by 
Scatchard plot, according to the method of Rosenthal (1967). (see 
main "Materials and Methods" section for details of Scatchard analysis.)
Results ;
Preliminary equilibrium dialysis experiment; As illustrated in Fig 34, 
the concentration of radioactivity in the solution outside the dialysis 
bag decreased with time from 40,000 cpm until equilibrium was reached. 
After the point of equilibrium a constant value of about 32500 cpm was 
recorded. From these values it was estimated that approximately 0.8% 
of the total counts added were bound. In the subsequent experiment, 
dialysis was continued for 30 hours, to ensure that equilibrium was 
reached.
Equilibrium dialysis; The concentration of radioactivity was measured
inside and outside each dialysis bag, and the results shown in Table 12,
These data were expressed on Scatchard plots (see Figs 35 and 36), A
high affinity progesterone-binding component was evident in the maternal
serum control, with an intrinsic association constant (Ka) of 6.56 x 
9 -1
10 M . A considerable increase in the amount of steroid bound was 
evident at the highest concentration of steroid used (20 nmolar). This 
may indicate the presence of a nonspecific, low affinity progesterone- 
binding component of high capacity, ie. the binding sites are only 
saturated at high concentrations of steroid. In contrast to the 
maternal serum results, there was no evidence of a correlation between
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the bound : unbound ratio and the amount of steroid bound in the case 
of partially-purified AUP. This suggests a lack of any major specific 
progesterone-binding component of high affinity. However, as in 
maternal serum, a marked increase in the amount bound at the highest 
steroid concentration may indicate the presence of a low affinity 
component.
Discussion; The specific progesterone-binding component in maternal 
serum is likely to be corticosteroid-binding globulin (also known as 
transcortin) which binds cortisol and progesterone with high affinity. 
The normal range of this receptor protein in adult human female serum 
is 3.3 - 0.42 mg/100 ml. During pregnancy, however, the concentration 
in maternal serum rises, reaching a maximal value of approximately 
7 mg/100 ml by the middle of the second trimester, after which the 
concentration remains stable to term (Doe 1964),
No evidence was found of any specific, high affinity 
progesterone receptor in the partially-purified AUP, This was illus­
trated by the lack of correlation on the Scatchard plot. In addition, 
comparison of the bound to unbound steroid ratio and the amount of 
steroid bound with the control results reveals that a negligible amount 
of steroid was bound by partially-purified AUP, However, some binding 
of progesterone was apparent in the preliminary equilibrium dialysis 
experiment. This may reflect nonspecific binding by a low affinity 
(Ka ^  lO^M )^ receptor, since the preliminary experiment was carried out 
using the highest steroid concentration (20 nmolar) and the binding 
sites of low affinity receptors are only saturated at high steroid 
concentrations. In addition, the AUP solution was partially-purified 
from amniotic fluid which contains many serum proteins including
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albumin and orosomucoid, both of which bind progesterone with low 
affinity.
Since the concentration of AUP in the partially-purified 
material is not known, it is possible that AUP does bind progesterone but 
is not present in a sufficiently high concentration for binding to be 
detected. Thus it is unlikely for two reasons; firstly specific 
receptor proteins are characterised by a high association constant 
(Ka ^ lO^M ie, steroid is bound even when the receptor is present in 
very low concentrations (Baulieu et al, 1970), Secondly, AUP is 
detectable in the partially-purified material by antigen-antibody 
crossed electrophoresis, therefore lies within the concentration range 
of 5-50 mg/100 ml (Laurell, 1972), In comparison, the concentration of 
corticosteroid-binding globulin in maternal serum, which binds proges­
terone under the same experimental conditions, is at the lower end 
of this range. Another possibility is that AUP binds progesterone 
but is an unstable receptor, ie. under the experimental procedure 
employed either to partially-purify this material or to measure
II
steroid-binding there is a loss of binding activity. Janne £t ^  (1975) 
reported that the human uterine progesterone receptor was unstable in 
that attempts to purify it by classical purification techniques 
resulted in the loss of binding activity. In addition, it was unstable 
at pH values less than 6.9 and greater than 9. However, the fact that 
the AUP used in the present experiment was partially-purified by ion 
exchange chromatography only and equilibrium dialysis was carried out at 
physiological pH, argues against this possibility.
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Table 12; Equilibrium dialysis; bound and unbound radioactivity as 
measured by liquid scintillation counting.
Cone, of 
(1,2-%)
Progesterone
(nmolar)
Total steroid 
added 
(molesxlO*^^)
Total cpm 
added 
(xlO&)
(W
(u)
(b)
(moles X 10 ^^)
•dd
•H
•H
5-1
i—tCti
•H+J
d
P4 ,
0.2
0.5
1
2
5
10
15
20
3
7.5
15
30
75
150
225
300
0.33
0.825
1.65
3.3
8.25
16.5
24,75
33
0.026
0.058
0.126
0.124
0.056
0.088
0.079
0.116
0.02
0.13
0.69
1,10
0.37
1,60
1.85
10.35
g0)+j
S
0.2
0,5
1
2
5
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15
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3
7.5
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75
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0.33
0.825
1,65
3.3
8.25
16.5
24.75
33
6.37
5.66
4.74
4,95
4.72 
1.81
2.72 
0.56
4.61
8.39
16.14
31.41
22.48
71,39
55.59
207.61
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Fig. 35. Scatchard plot of results of progesterone-binding
experiment using maternal serum as source of receptor(s). (Control)
Slope of line, -k = intrinsic association constant.
k.n.(M) =6,5 moles steroid bound/0.6 rag protein/ml/mole
“1= 10.83 moles steroid bound/g protein/l/mole 
-11n.(M) = 99 X 10 moles steroid bound/0.6 mg protein/ml
= 165 X 10 moles steroid bound/g protein/1.
k =
k.n.(M)
n7(mT
10.83 
165 X 10-11
6.56 X 10^
(intrinsic assoc, constant 
of high affinity component.)
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Fig. 36. Scatchard plot o£ results of progesterone-binding
experiment using partially-purified AUP as source 
of receptor(s).
GENERAL DISCUSSION
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Alpha uterine protein was first isolated from human amniotic 
fluid and subsequently detected in endometrium, myometrium, early 
gestation decidua, amnion and chorion by one-dimensional AAGE (Sutcliffe 
et al, 1978), In this thesis several additional sources of AUP are 
reported, namely late gestation decidua, early gestation and term 
placentae and 17 week fetal gut. The protein known as "progestagen- 
dependent endometrial protein" (PEP), which has been shown to be identical 
to AUP, has also been reported in endometrium from both phases of the 
menstrual cycle, and early gestation decidua (Joshi et al, 1980a), The 
inability to detect PEP in term placenta (Joshi ejt al, 1980a) probably 
reflects the insensitivity of the assay techniques used, ie, immuno- 
electrophoresis and double immunodiffusion relative to AACE, Similarly, 
AUP may be present in other tissue and fluids in concentrations below 
the limits of detection by one-dimensional AAGE, There is some 
evidence that this is the case: although AUP cannot be detected in
maternal serum by immunodiffusion or one-dimensional AACE (Sutcliffe 
eb 1978; Joshi et al, 1980a), low concentrations have been detected 
in this fluid by radioimmunoassay (R,G, Sutcliffe and colleagues, in 
preparation). Therefore, although the major sources of AUP are known, 
the complete tissue distribution remains to be established.
The available evidence argues strongly in favour of identity 
between AUP from the two major sources: uterine decidua and amniotic
fluid, ie, decidual and amniotic fluid AUP are similar as regards 
molecular size, electrophoretic mobility on agarose gel and immuno­
logical cross-reactivity, and, from the studies on PEP, glycoprotein 
nature and isoelectric point. However, some anomalous findings are 
reported in this thesis. Firstly, there is an alteration in the normal
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AUP precipitin peak morphology on AAGE which is apparently a feature 
of antibody/antigen specificity in that it is only observed with anti­
sera raised against decidual AUP. The cause of this altered peak 
morphology is not known, although it may indicate incomplete antigenic
identity between AUP from these two sources. In addition, analysis of
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immune-precipitated I-AUP (partially-purified from amniotic fluid)
by SDS-polyacrylamide gel electrophoresis under denaturing conditions 
resulted in three bands of molecular weights 48,000, 16,000 and 9,000,
This contradicts previous reports that AUP of decidual origin is a 
dimer of MW 50,000, composed of two similar or identical polypeptide 
chains (Sutcliffe et al, 1980; Joshi et al, 1980b). This may indicate 
that amniotic fluid AUP has a different subunit structure from that 
found in uterine decidua. However since these findings are unconfirmed 
it is impossible to discount alternative hypotheses that either some 
physical alteration of AUP occurred during the purification procedure 
or subsequent radio-iodination, or that the 16000 and 9000 molecular weight 
bands observed represent serum protein contaminants.
Second trimester amniotic fluid is readily-available due to the 
routine practice of amniocentesis, therefore appears to be an ideal source 
of AUP for use in a large scale purification of this protein. However, 
due to problems of a largely technical nature the attempt to purify AUP 
from amniotic fluid using the three-step method of antibody affinity 
chromatography, ion exchange chromatography and gel filtration described 
by Sutcliffe ^  ^  (1980) proved unsuccessful. The initial antibody 
affinity chromatography step resulted in a 39% recovery of AUP which 
is identical to the recovery of AUP from 11 week uterine decidua reported 
previously (Sutcliffe et al, 1980), In addition, there was considerable 
enrichment of AUP after this step together with a marked reduction in
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protein content, ie. only 4% of the total protein applied to the 
affinity column was recovered in the eluted material (see Table 6). 
However, affinity chromatography was not entirely satisfactory as a 
step in the purification of AUP from amniotic fluid because the concen­
tration of AUP is much lower in amniotic fluid than in 11 week decidua. 
Therefore in order to obtain measurable amounts of AUP it was necessary 
to apply a much larger volume of amniotic fluid as compared to decidual 
homogenate to the column. This in turn resulted in a higher degree 
of serum protein contamination when amniotic fluid was used as source 
material in the purification of AUP,
Ion exchange chromatography is a more suitable method than 
affinity chromatography for use in the purification of AUP from amniotic 
fluid because an ion exchange column has a greater protein carrying 
capacity per ml bed volume than an affinity column. Thus the problem 
of overloading the column is minimised. In addition, if the correct 
gradient of ionic strength is used, good separation of minor protein 
components can be achieved. Since the initial ion exchange step 
(during the three-step purification procedure) resulted in a good recovery 
of AUP and relatively good initial separation from contaminant proteins 
this was used as the first stage in the subsequent two-step purification 
procedure. Con-A Sepharose chromatography was used as the second 
stage because this is a highly-selective technique for the separation 
of glycoproteins. It was particularly useful in the purification of 
AUP from amniotic fluid because the quantitatively major protein contam­
inant, serum albumin, is not a glycoprotein hence does not bind specifi­
cally to Con-A. Although there was only a 20,5% recovery of AUP after 
this step (see Table 9), further enrichment of this protein occurred
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and serum protein contamination was reduced. In particular, there was 
an approximately 12-fold reduction in the serum albumin concentration 
as compared to that in the material applied to the Gon-A Sepharose 
column (see Fig 26). Therefore the two-step procedure of ion exchange 
chromatography and Con-A Sepharose chromatography resulted in partial 
purification of AUP with loss of the majority of the major contaminant, 
serum albumin. However, due to the low recovery of AUP from the Con-A 
Sepharose chromatography step further purification was not attempted.
Although the tissue distribution of AUP is fairly well- 
established, until recently there was little information on the actual 
site(s) of synthesis of this protein. As previously mentioned (see
"introduction") the consistent presence of AUP in both pregnant and
non-pregnant uterine tissue suggested that this was the most likely site
of synthesis. This has been confirmed by Joshi ^  ^  (1980a), who
demonstrated synthesis of PEP in early gestation decidua, secretory 
phase endometrium and, to a much lesser extent, in proliferative phase 
endometrium. In addition, the exact cellular localisation of AUP 
within the endometrium has recently been established using an indirect 
immunoperoxidase technique. The results of this study indicate that 
AUP is present in the epithelial cells and secretions of the endometrial 
glands during the secretory phase of the menstrual cycle and during 
pregnancy (R.G. Sutcliffe and colleagues, in preparation). This 
clearly indicates that AUP is not only synthesised but also secreted by 
the progestational phase endometrium. The detection of AUP in placenta 
early in gestation (8-13 weeks) and at term by AACE suggests that AUP 
may be present in the placenta throughout gestation and that this may 
be an additional site of synthesis. Due to the close proximity of 
the placental trophoblast and decidua basalis after implantation.
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however, it is possible that the AUP detected in placental tissue was 
in fact present in decidual cells adherent to the placenta. The data 
on the quantitation of AUP in early gestation (8-13 weeks) decidua and 
placenta argues against this possibility in that the concentration of 
AUP is very similar in the two tissues at each stage of gestation. 
Clearly, if placental AUP was synthesised by random associated cells of 
decidual origin the concentration of AUP would be reduced relative to 
that in decidua. In addition, in the immunoperoxidase study described 
above AUP was also found to be localised within the placental tropho­
blast, although staining was somewhat weaker than that observed in 
endometrium (R.G. Sutcliffe and colleagues, in preparation). AUP has 
also been detected in fetal gut by one-dimensional AACE, therefore this 
may be an additional site of AUP synthesis. Alternatively, the presence 
of AUP in the fetal gut may reflect swallowing of amniotic fluid by the 
fetus in utero, which is well-established by 17 weeks of gestation 
(Pritchard, 1965, 1966; Abramovich, 1970), The amnion and chorion 
may also be sites of AUP synthesis, but as yet there is no evidence to 
support this hypothesis.
The origin and possible routes of entry of AUP into the 
amniotic fluid have not yet been established, A decidual and/or 
placental origin appears most probable early in gestation, since 
secretion of AUP by the decidual glandular epithelium has been demon­
strated and relatively high levels of AUP are found in both these 
tissues between 8 and 13 weeks of gestation, which precedes the period 
of high AUP concentration in amniotic fluid from 15-18 weeks (Sutcliffe 
e_t 1978). However, although there is an approximately ten-fold 
decline in the concentration of AUP in amniotic fluid between 12 weeks
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of gestation and term, a much more considerable decline is apparent 
between early gestation and term in both decidua and placenta. This 
reduction in AUP concentration is to the order of 50- to 100-fold in 
decidua and 400- to 3000-fold in placenta. This may reflect either a 
dramatic decrease in the rate of synthesis of AUP with gestation in 
these tissues, or a less marked decline in synthesis together with 
increased secretion of AUP, Therefore, until these two possibilities 
are distinguished the origin of AUP in amniotic fluid late in gestation 
remains uncertain. As stated in the "introduction", decidual AUP is 
more likely to enter the amniotic fluid via the "reflected" fetal 
membranes than by passage across the placental chorionic plate and 
associated amnion, because the chorionic plate is bathed with maternal 
blood. Clearly, AUP does not enter the amniotic fluid along with 
maternal serum proteins of similar^ molecular size because its concen­
tration profile in amniotic fluid between 12 weeks of gestation and 
term differs from that of known maternal serum proteins (Queenan £t al, 
1970; Sutcliffe and Brock, 1972; Sutcliffe al, 1978). In addition, 
only trace amounts of AUP are detectable in maternal serum (R.G, Sut­
cliffe and colleagues, in preparation). There are several possible 
routes by which placental AUP may enter the amniotic fluid. Firstly,
AUP synthesised in the placental trophoblast may enter the surrounding 
maternal blood and cross the chorionic plate and amnion. For the 
reasons presented above AUP entering the amniotic fluid by this route 
is unlikely to contribute significantly to the amniotic fluid AUP pool. 
Secondly, AUP may enter the fetal blood vessels within the placenta and 
permeate into the amniotic fluid via the umbilical cord, Abramovich 
and Page (1972) demonstrated that the fetal skin and cord epithelium 
are permeable to fluid and some dissolved solutes up to mid-trimester.
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Therefore it is possible that some exchange of proteins also occurs across 
the umbilical cord. The final and most likely route of entry of 
placental AUP into the amniotic fluid is by direct passage from the 
placental trophoblast across the chorionic plate and amnion. This, 
however, presupposes that an area of the placenta is not engulfed with 
maternal blood, but lies in close apposition to the chorionic plate.
An attempt to establish the origins in amniotic fluid of 
AUP, prolactin and #l,4-glucosidase by comparing levels of these 
proteins in 20 samples of second trimester amniotic fluid proved un­
successful. The apparent lack of correlation between levels of AUP 
and al,4-glucosidase may indicate that these two proteins have different 
origins in amniotic fluid, A correlation was previously found between 
levels of al,4-glucosidase and heat-labile alkaline phosphatase between 
13 and 18 weeks of gestation in separate samples of amniotic fluid 
(Sutcliffe et al, 1972b), This period of gestation corresponds to the 
early activity peak of heat-labile alkaline phosphatase in amniotic fluid. 
There is some evidence that the majority of this early activity may be 
due to the fetal intestinal type of this enzyme (Mu 1 Ivor e_t al, 1979), 
Previous studies have indicated that the al,4-glucosidase present in 
amniotic fluid and kidney is a different enzyme from the al,4-glucosidase 
found in amniotic fluid cells, fibroblasts, leucocytes and liver which is 
deficient in Pompe's disease (Salafsky and Nadler, 1971a; Fluharty 
et al, 1973). However, fetal kidney is unlikely to be major source 
of al,4-glucosidase in amniotic fluid (see "introduction"). There­
fore, characterisation of the type of al,4-glucosidase present in decidua, 
fetal secretions and other fetal tissues, eg. skin, may resolve the 
question of the origin of this enzyme in amniotic fluid. Unfortunately,
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the levels of amniotic fluid prolactin, which is almost certainly 
derived from the decidua and possibly the chorion could not be compared 
with the AUP and al,4-glucosidase concentrations because of non-linearity 
of the radioimmunoassay results at different dilutions. As stated 
before, this may reflect alteration of the prolactin molecule caused 
by storage at -20*^ C, Thus, the observed nonlinearity may reflect 
measurement of a heterogeneous population of prolactin molecules which 
have different affinities for the anti-prolactin serum.
In contrast to the results for the probable non-serum proteins 
in the amniotic fluid samples, a strong positive correlation was 
observed between the three serum proteins measured: albumin, Gc and
a^-antitrypsin. As previously stated, Gc is a known maternal serum 
marker, hence this result is compatible with the proposed maternal 
serum origin of albumin and a^^-anti trypsin (Gitlin al, 1964;
Queenan ejt al, 1970; Sutcliffe and Brock, 1973; Johnson e_t 1974).
If either albumin or a^-antitrypsin originated from the fetus as has 
been suggested (Brzezinski £t al, 1964; Kaiser et al, 1974), it is 
unlikely that such a relationship between their concentrations and 
that of Gc would have been evident. The fact that no correlation was 
observed between Gc and alpha fetoprotein, a fetal marker, supports 
this hypothesis. In addition, the molecular weight of a^-antitrypsin 
is similar to that of Gc which freely permeates into the amniotic fluid 
from maternal serum, therefore it is unclear how a fetal a^-antitrypsin 
deficiency as described by Kaiser e_t al (1974) could affect passage of 
maternal a^-antitrypsin into the fluid.
The physiological function of AUP is not yet known. However, 
some suggestions of possible functions can be made with regard to the 
available information on tissue distribution, sites of synthesis and
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concentration changes during gestation. From the distribution of AUP 
it is apparent that a pregnancy-associated function is most likely. 
However, synthesis of this protein has been demonstrated not only in 
decidual tissue but also in nonpregnant endometrium throughout the 
menstrual cycle (Joshi et al, 1980a), The rate of synthesis of AUP is 
higher in the decidua and secretory phase endometrium than in the prolif­
erative phase endometrium, which may indicate that progesterone is 
involved in the synthesis and/or function of this protein. However, 
the results of the progesterone-binding study indicate that it is 
unlikely that AUP functions as a progesterone receptor. Although there 
is no direct evidence that progesterone has a role in the regulation of 
AUP synthesis, the increased rates of synthesis in the progestational- 
phase uterus suggest that this is likely.
Unfortunately, few studies have been carried out on human 
uterine-specific proteins during pregnancy. Most studies to date have 
involved the investigation of proteins present in the uterine fluid 
during the nonpregnant cycle. From such studies it is apparent that 
there is no quantitatively -dominant nonserum protein in the uterine 
secretions during the menstrual cycle. Also, the pattern of non-serum 
proteins is similar at both phases of the cycle (Maathuis and Aitken, 
1978b), This is in direct contrast to the situation in most other 
mammals, in which there is a marked increase in uterine secretory 
activity during the pre-implantation (mid-luteal) period. In some cases 
this phase is characterised by the appearance of a dominant non-serum 
protein, eg, purple glycoprotein in the pig and uteroglobin in the rabbit 
(Aitken, 1979b), In humans, however, quantitatively minor components 
of the uterine fluid may have important functions. Alternatively, 
proteins with important pregnancy-associated functions may be synthesised
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within the endometrium during the menstrual cycle but only released if 
fertilisation occurs. The stimulus for release of such proteins might 
be fertilisation or, more probably, implantation. In the case of AUP 
either of these two hypotheses may be correct since it is not known if 
this protein is present in the uterine fluid during the menstrual cycle. 
The possibility that the implanting blastocyst may stimulate uterine 
secretory activity in humans remains to be investigated. However, 
there is evidence that implantation causes a local increase in uterine 
secretory activity in the mouse, rabbit, wallaby and pig (Daniel, 1972; 
Renfree, 1972, 1973; Wyatt e_t 1976; Aitken, 1977b),
It has been suggested that AUP may have a role in the regu­
lation of pre- or post-implantation embryonic development (Joshi ^  al, 
1980b), Alternatively, AUP may be involved in the control of the 
actual implantation event. In humans, implantation is complete and the 
embryonic circulation established by about the 4th week after fertili­
sation (Corliss, 1976), Relatively high concentrations of AUP are 
present in the decidua and placenta between 8 and 13 weeks of gestation, 
but levels in these tissues before 8 weeks are not known. If secretion 
of AUP is induced by the implanting blastocyst and/or the AUP concen­
tration is low during the first 8 weeks of gestation then a major role 
in the regulation of implantation or pre-implantation embryonic 
development is unlikely. Conversely, elevated levels of AUP during 
this period may indicate that such a role is possible. In either 
event, a regulatory role for AUP during the post-implantation period 
cannot be discounted. Other possible functions of AUP have been 
described already in the "Introduction", These include a minor role 
in fetal nutrition and the transportation of essential elements between 
the mother and fetus. Alpha uterine protein may serve either of these
functions in vivo, although at present there is no evidence in support 
of this.
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Conclusions and future objectives
The results presented in this thesis have contributed to some 
extent to our knowledge of the human protein known as alpha uterine protein or 
progestagen-dependent endometrial protein. However, there are 
several unresolved questions remaining and it is hoped that future 
research on this protein may elucidate these points. One such question 
is whether AUP from amniotic fluid is identical to that found in uterine 
decidua. Although AUP from these two sources appears to be biochemic­
ally and immunologically identical it has been shown that antisera 
raised against amniotic fluid and decidual AUP produce precipitin arcs 
of different morphology on AAGE. In addition, amniotic fluid AUP may 
have a different subunit structure to uterine AUP, Therefore AUP from 
these two sources may be structurally dissimilar. Clearly, it is
important to obtain purified amniotic fluid AUP in order to compare its
structure with that of uterine AUP, The major problem associated with
the purification of AUP from amniotic fluid is the relatively low
concentration of this protein in the fluid. Therefore a successful 
purification technique must provide a means of enriching AUP without a 
concommitent increase in the concentration of the contaminating serum 
proteins, particularly serum albumin. Prior concentration of amniotic 
fluid (eg. by ultrafiltration) followed by specific removal of serum 
albumin by column chromatography may prove useful as a preliminary step 
in a future purification of AUP from amniotic fluid.
The discovery of AUP in placental tissue has not only contributed 
to data on the tissue distribution of this protein but also poses some 
interesting questions about the nature and function of AUP, This is 
particularly interesting in view of recent evidence that the AUP
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detected in the placenta by AAGE is present in the placental trophoblast 
cells, rather than in associated cells of decidual origin (R.G, Sutcliffe 
and colleagues, in preparation).
Although this protein has been termed "progestagen-dependent", 
there is as yet no direct evidence that progesterone is involved in the 
synthesis and/or function of AUP, However, increased synthesis of 
AUP in progestational-phase endometrium (Joshi et al, 1980a) suggests 
that this may be the case, AUP does not appear to be a progesterone- 
receptor, but it is possible that progesterone acting at its progesterone- 
receptor may thereby induce AUP synthesis. In vitro studies using 
cultured human endometrial cells, in which progesterone is added to 
the culture medium and levels of AUP in the cells and medium monitored, 
may resolve this question.
The major objective in any future study of AUP must be to 
establish the physiological function of this protein. Although AUP is 
synthesised in non-pregnant endometrium (Joshi et al, 1980a), it is not 
known whether it is secreted into the uterine fluid, or if secretion 
occurs only during pregnancy. From this, it may be deduced whether 
the function of AUP is associated solely with pregnancy. Therefore it 
is important to ascertain whether AUP is present in the uterine fluid 
during the normal menstrual cycle. Further information on the 
distribution and sites of synthesis of AUP may also aid in the 
elucidation of its function.
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